Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 472.50
Bid: 470.00
Ask: 475.00
Change: -12.50 (-2.58%)
Spread: 5.00 (1.064%)
Open: 485.00
High: 485.00
Low: 472.50
Prev. Close: 485.00
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results for the year ended 31 December 2022

26 Apr 2023 07:00

RNS Number : 4456X
Warpaint London PLC
26 April 2023
 

26 April 2023

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

Results for the year ended 31 December 2022

Record sales and significant profitability reflect strong full year performance; positive start to 2023

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands is pleased to announce its audited results for the year ended 31 December 2022.

Financial Highlights

 

·

Strong growth in sales to reach a record level for the Group. Significant profitability and cash generation during the year reflecting the focus on growing sales of the Group's branded products

 

·

In 2022 Group sales increased by 28% to £64.1 million (2021: £50.0 million)

 

· UK revenue increased by 9% to £27.6 million (2021: £25.3 million)

 

· International revenue increased by 48% to £36.5 million (2021: £24.7 million)

 

·

Gross profit margin increased to 36.4% (2021: 33.8%), despite continued supply side price inflation

 

·

EBITDA increased 56% to £11.7 million (2021: £7.5 million)

 

·

Adjusted profit from operations of £10.3* million (2021: 7.0* million). Statutory profit from operations of £8.0 million (2021: £3.8 million)

 

·

Reported profit before tax of £7.7 million (2021: £3.7 million)

 

·

Adjusted earnings per share increased by 44% to 11.2p* (2021: 7.8p*)

 

·

Cash of £5.9 million at 31 December 2022 (31 December 2021: £4.1 million), with no debt

 

·

Final dividend recommended of 4.5 pence per share (2021: 3.5 pence per share), bringing the total dividend for the year to 7.1 pence per share (2021: 6.0 pence per share)

 

*Adjusted numbers are closer to the underlying cash flow performance of the business which is regularly monitored and measured by management, the adjustments made to the statutory numbers are set out in the table below

 

Operational Highlights

·

European sales increased by 56% to £28.1 million (2021: £18.0 million), making this the largest sales region for the Group

 

·

Successful launch in Boots of 45 W7 products in an initial 80 stores

 

·

USA sales, in sterling terms, increased by 79% in 2022 to £5.3 million (2021: £3.0 million) and grew by 55% in US dollar terms

 

·

Direct online sales continue to accelerate, with an increase of 106% in Group e-commerce sales in 2022 to account for 4.3% of Group sales (2021: 2.7% of Group sales)

 

Post-Period End Highlights

· Continued strong trading in Q1 2023, with unaudited Group sales for the three months to 31 March 2023 of £18.5 million an increase of 40% on the same period in 2022 (3 months to 31 March 2022: £13.2 million)

 

· Margins in Q1 were robust and better than those achieved in the full year 2022

 

· Q1 2023 e-commerce sales of £0.83m, 188% ahead of the same period in 2022 (Q1 2022 £0.29m)

 

· Record cash in bank of £8.6 million as at 31 March 2023 and no debt

 

· Continuing brand sales momentum being seen in 2023:

In April 2023, a range of 158 Technic products will be launched in an initial four Asda superstores on a trial basis with a view to a wider inclusion in Asda's cosmetic range review in Q4 2023

 

After an initial trial of W7 product in 20 New Look stores in the UK, the Group is now rolling out W7 product to a further 200 New Look stores

 

Significant further expansion in the US with H-E-B stores, CVS BIRL stores, where initial sales have been ahead of expectations, as well as launching in Sallys and Nordstrom Rack

 

 

Commenting, Clive Garston, Chairman, said: "I am very pleased with Warpaint's strong performance in 2022, which reflects the Group's consistent and focussed strategy. We have concentrated on increasing our presence in larger retailers in all our major markets, both through growing sales to existing customers and entering into new relationships. This strategy of increasing sales to larger customers and providing products that their customers want is reflected in the Group's results and provides a strong platform for the future. In addition, growing our online presence is a prime objective of the Group.

"Trading has continued to be strong in the first quarter of 2023, with the Group enjoying record first quarter sales. I am optimistic that the strong performance we have seen in 2022 and into 2023 will continue and that we have the right offering and strategy in place to continue to deliver profitable future growth, despite the backdrop of macroeconomic uncertainty."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018

 

Enquiries:

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

c/o IFC

 

 

Shore Capital (Nominated Adviser & Broker)

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

020 7408 4090

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Chandler

020 3934 6630

 

 

Warpaint London plc

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using its other brand names of Man'stuff, Body Collection and Chit Chat.

 

HEADLINE RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022

Statutory Results

Year ended 31 Dec 2022

Year ended 31 Dec 2021

Revenue

£64.1m

£50.0m

Profit from operations

£8.0m

£3.8m

Profit margin from operations

12.4%

7.6%

Profit before tax ("PBT")

£7.7m

£3.7m

Earnings per share ("EPS")

8.1p

3.7p

Cash and cash equivalents

£5.9m

£4.1m

 

Adjusted Statutory Results

Year ended 31 Dec 2022

Year ended 31 Dec 2021

Revenue

£64.1m

£50.0m

Adjusted profit from operations

£10.3m*

£7.0m*

Adjusted profit margin from operations

16.1%*

13.9%*

Adjusted PBT

£10.0m*

£6.9m*

Adjusted EPS

11.2p*

7.8p*

Cash and cash equivalents

£5.9m

£4.1m

 

Adjusted numbers are closer to the underlying cash flow performance of the business which is regularly monitored and measured by management, the adjustments made to the statutory numbers are as follows:

 

2022

2021

Statutory profit from operations

£7.97m

£3.82m

Exceptional items

£0.15m

£0.58m

Amortisation

£2.00m

 £2.39m

Share based payments

£0.19m

£0.18m

*Adjusted profit from operations

£10.31m

£6.97m

 

 

 

*Adjusted profit margin from operations

£10.31m / £64.06m = 16.09%

£6.97m / £50.00m = 13.94%

 

 

 

Statutory PBT

£7.69m

£3.73m

Exceptional items

£0.15m

£0.58m

Amortisation

£2.00m

£2.39m

Share based payments

£0.19m

£0.18m

*Adjusted PBT

£10.03m

£6.88m

 

 

 

Statutory profit attributable to equity holders

£6.25m

£2.83m

Exceptional items

£0.15m

£0.58m

Amortisation

£2.00m

£2.39m

Share based payments

£0.19m

£0.18m

Adjusted profit attributable to equity holders

£8.59m

£5.98m

Weighted number of ordinary shares

76,752,355

76,751,187

*Adjusted EPS

11.19p

7.80p

Exceptional items include £nil of staff restructuring and voluntary redundancy costs (2021: £0.03 million), £nil of non-recurring legal costs (2021: £0.18 million), and £0.15 million for content use and associated legal fees (2021: £0.37 million).

CHAIRMAN'S STATEMENT

Warpaint's business strategy and model has enabled it to withstand the difficult business environment driven by rampant inflation, the war in Ukraine and the aftermath of the Covid epidemic to deliver a very good performance in 2022 and to be in a position to grow further in all its markets. This is due to the dedication of all the Warpaint team and I would like to thank them very much for their energy, flexibility and exceptional efforts. Relationships with our major customers and suppliers continue to be very strong.

During the year we continued our strategy of focusing on increasing our presence in larger retailers globally, through growing sales through our existing relationships and entering into new ones, together with growing our online presence. This focus on larger customers and doing more business with them is reflected in the Group's results and provides a strong platform for the future.

Trading has continued to be strong in the first quarter of 2023, with the Group enjoying record quarterly sales. We expect demand to remain buoyant and for sales to continue to grow, despite the macroeconomic headwinds. 

Results

2022 was a year of significant achievement for the Group, with record sales and profits being delivered.

Adjusted profit from operations was £10.3 million (2021: £7.0 million) on revenue of £64.1 million (2021: £50.0 million) with basic earnings per share of 7.9p (2021: 3.7p) and adjusted earnings per share of 11.0p (2021: 7.8p). Adjusted numbers exclude exceptional costs (staff restructuring and voluntary redundancy costs, certain non-recurring legal costs, stock relocation costs and a provision for content use and associated legal fees), amortisation in relation to acquisitions and share based payments.

Whilst continuing to focus on quick stock turnover, the Group ensured inventory levels were appropriate at the year end to service the anticipated demand in the first quarter of 2023, with inventory at 31 December 2022 increasing to £18.7 million (31 December 2022 £18.1 million). The balance sheet remains strong, with cash at 31 December 2022 of £5.9 million (31 December 2021: £4.1 million), and the Group remains debt free.

Dividend

In accordance with the Group's policy to continue to pay appropriate dividends, the board is pleased to recommend an increased final dividend of 4.5 pence per share which, if approved by shareholders at the AGM, will be paid on 4 July 2023 to shareholders on the register at 16 June 2023. The shares will go ex-dividend on 15 June 2023.

Board

John Collier, an independent non-executive director of the Company, left the board on 31 December 2022 to focus on his other business interests. I would like to thank John for his contribution to Warpaint and we wish him well in his future endeavours. It is the board's intention to appoint an additional non-executive director in the second half of 2023.

 

Annual General Meeting

The Company's annual general meeting will be held at the Company's offices at Units B&C, Orbital Forty Six, The Ridgeway Trading Estate, Iver, Bucks, SL0 9HW on 28 June 2023 at 10 a.m. and we will be delighted to welcome those shareholders who are able to attend in person.

Summary and Outlook

I am very pleased with the Group's strong performance in 2022 and that this has continued in the first quarter of 2023, with the Group enjoying record quarterly sales. This reflects Warpaint's consistent and focused strategy of increasing our presence in large retailers globally, both by growing sales through our existing relationships and entering into new ones, together with increasing our online presence. This focus on larger customers, doing more business with them and providing what their customers demand is reflected in the Group's results and provides a strong platform for the future. We also continue to develop relationships with other large retailers, particularly in the UK, Europe and the US, where they are seeing demand from their customers for quality, on trend, but more value orientated brands, such as those produced by the Group.

Notwithstanding the current situation in the Ukraine and current levels of inflation I am optimistic that the strong performance we have seen in 2022 and into 2023 will continue and that we have the right offering and strategy in place to continue to deliver profitable future growth, despite the macroeconomic headwinds.

Clive Garston

Chairman

25 April 2023

 

CHIEF EXECUTIVE'S STATEMENT

 

The Group achieved a record level of sales in 2022, reflecting the success of the Group's strategy of focusing on growing sales of its branded products. This was achieved at an improved gross margin, despite a number of continuing operational challenges being faced, particularly with regard to supply side price inflation.

In 2022, Group sales increased by 28% in 2022 to £64.1 million, reaching a record level for the Group. These sales were achieved at an increased gross margin of 36.4% (2021: 33.8%) despite continued cost pressures and resulted in a reported profit before tax of £7.7 million (2021: £3.7 million). Gross margin is being maintained in Q1 2023 despite the current economic challenges.

Our strategy of producing a wide range of high-quality cosmetics at an affordable price remains our key focus, growing sales through our existing customers' outlets and winning new customers with significant sales footprints, both in the UK and internationally, together with continuing to grow our online sales. The global cosmetics market is increasingly seeing customers transferring to more value orientated brands, such as those produced by the Group, and I believe we are very well placed with our high-quality focused offering to capture further market share.

Following the rationalisation of our brand portfolio in 2020 the Group has concentrated on its core W7, Technic, Body Collection, Man'stuff and Chit Chat brands during the year. In 2022, sales of the Group's branded products accounted for 90% of revenue (2021: 89%).

Warpaint has continued to reduce the focus on its close-out business, although profitable close-out opportunities continue to be taken where appropriate. In 2022 close-out sales accounted for £3.8 million (2021: £4.5 million), 6% of Group sales. The remainder of the Group's sales of £2.6 million (2021: £1.1 million) are white label products for major high street retailers.

W7

The Group's lead brand remains W7, with sales in 2022 accounting for 55% of total Group revenue (2021: 52%). Overall W7 sales increased by 35% in 2022 to £35.0 million compared to £25.9 million in 2021.

In the UK, W7 revenues were up 7% in 2022 compared to 2021, representing 37% of W7 sales in the year, down from 46% in 2021, as stronger sales growth was experienced in regions outside of the UK and higher than normal levels of inventory were held by certain UK retailers at the start of the year. W7 revenues in the UK grew by increased sales into Tesco, together with a growth in sales from the Group's other larger customers in the UK. W7 sales in the UK also received a further boost with Boots starting to stock a range of approximately 45 W7 products in an initial 80 stores from February 2022. Sales to date from Boots have been encouraging and we anticipate an increased presence with Boots in due course.

The strongest growth in 2022 was seen in continental Europe, with sales increasing by 77% compared to 2021, and continental Europe became the largest sales region for W7 branded products in the year, accounting for 45% of W7 sales. The Group has benefited from its post Brexit fulfilment strategy, enabling products to enter the EU without issues, and the growth in both the range of European customers served and the expansion in the number of outlets for certain larger customers.

In the US, W7 sales doubled in 2022 compared to 2021, and accounted for 13% of overall W7 sales, with the Group benefiting from the increased number of customers and outlets in the US.

In the rest of the world, W7 sales declined marginally, largely reflective of the timing of certain large orders.

We believe that W7 has a compelling brand proposition and will continue to benefit from consumers wanting a high quality, on trend, but excellent value-for-money product.

Technic

Since the Company's acquisition of Retra Holdings Limited ("Retra") and its Technic, Body Collection and Man'stuff brands in November 2017, the focus has been on growing the sales of all year-round cosmetics in addition to continuing to grow its strong and established gifting proposition. It was pleasing to see sales of Technic and the other Retra brands, including Body Collection, grow by 23% in 2022. As a result of the ongoing successful execution of this strategy, the proportion of gifting sales for Retra reduced to 34% in 2022, from 37% in 2021 and 47% in 2020, with single products sold under the Technic brands accounting for 66% of sales in 2022.

Sales of branded Technic product in 2022 was 36% of total Group revenue (2021: 37%). Overall Technic brand sales grew by 23% in 2022 to £22.7 million compared to £18.5 million in 2021.

In 2022, UK revenues were 46% of Technic's total sales and they increased by 24% over the year, aided by sales of Technic and Body Collection branded products to the retailer, Bodycare. In April 2023, a range of 158 Technic products will be launched in an initial four Asda superstores on a trial basis with a view to a wider inclusion in Asda's cosmetic range review in Q4 2023.

As with W7, sales of the Technic brands grew strongly in continental Europe during the year and accounted for 48% of Technic's sales in 2022, an increase of 34% compared to 2021, making continental Europe the largest sales region for the Technic brands.

Sales for the Technic brands outside of the UK and Europe accounted for 6% of Technic sales (2021: 6%). In the USA, sales increased by 58% compared to 2021, and in the rest of the world sales increased by 18% compared to 2021, albeit the sales were small in these regions in the context of the Group as a whole being under 3% of total Group revenues.

Building on the successful sales of W7 branded product through Amazon, a Technic brand store was launched on Amazon in the UK in January 2023 and a number of key Technic lines will be launched on Amazon in the US in Q2 2023 and in continental Europe later in 2023.

The Technic business also produces and sells own brand white label cosmetics for several major high street retailers, with such sales more than doubling to be 4% of Group revenue (2021: 2%). Despite the growth in white label sales in 2022, we continue to assess private label opportunities on a case by case basis, based on the return they can deliver.

Close-out

Close-out sales continue not to be a core focus for the Group, although advantage is taken of profitable close-out opportunities as they become available. The close-out division reduced as a proportion of Group sales in 2022, compared to 2021, representing 6% of the overall revenue of the Group (2021: 9%). Whilst not a core focus, this side of the business continues to provide a significant and profitable source of intelligence in the colour cosmetics market and access to new market trends.

e-Commerce

During 2022 we continued to focus on driving online sales. In addition to growing sales through the W7 and Technic brands' own bespoke e-commerce sites, the Group has continued to focus on growing sales of our brands in the UK and the US on Amazon, and in China through official W7 brand stores owned by the Group on Taobao Mall (Tmall), the most visited B2C online retail platform in China and Xiaohongshu (Red), one of China's foremost social media, fashion and luxury shopping platforms. Additionally, W7 product was launched on Amazon EU in Germany, Italy and Spain in 2022.

Direct online sales as a proportion of the Group's overall sales increased to 4.3% in 2022 (2021: 2.7%), having grown from £0.5 million in 2020 to £1.3 million in 2021, to over £2.8 million in 2022, an increase of 115% from 2021 to 2022.

Online sales have grown further in the current financial year, up 188% in Q1 2023 compared to the same period in 2022, and the focus remains on ensuring a similar margin to the Group's sales through traditional physical outlets. 

In 2023 the Group will launch online sales in Japan through Amazon, a similar model to that successfully deployed in the US, together with launches of the Technic brands on Amazon in the UK, US and continental Europe.

New Product Development

New product development continues to be core to the Group's proposition to provide new products that are on trend, fast to market and that meet the consumer's quickly changing needs.

During 2022 our New Product Development Team continued to develop a strong pipeline of new products, focused on the demands of our customers. Our new product development strategy continues to utilise a variety of manufacturing partners, predominantly in China and Europe, that provide high quality products quickly, at very competitive prices, and meet our legal and ethical compliance requirements, together with ensuring continuity of delivery. This process is supported by the Group's Hong Kong based subsidiary sourcing office and its China subsidiary (Jinhua Badgequo Cosmetics Trading Company Ltd), with local employees able to explore new factories and oversee quality control and ethical sourcing.

The Group's cosmetic products are "cruelty free" and are not tested on animals irrespective of where the products are being supplied. We support cruelty free alternatives to animal testing to become compulsory and animal testing overall to be ceased globally. We will now be proudly displaying the PETA company logo on our products for all new products and as packaging is updated. Our commitment to the PETA "Beauty without Bunnies program" is Group wide and covers all brands within the Group.

The Group is very focused on the environmental impact of its products and the Group is committed to becoming an industry leader for sustainable products and packaging. All unrecyclable plastics have now been removed from the outer packaging of our gifting, and we are progressing well with our journey of removing unrecyclable plastics from our all year-round products. The Group's product packaging therefore uses paper and cardboard wherever practicable, which enables the Group, the wholesaler and end user to recycle the waste effectively.

 

All new W7 brand products are being manufactured without parabens and the Company is reformulating existing products where feasible.  No heavy metals such as TBTO (preservative) and other ingredients of concern are added to our products and all raw materials comply with the strict regulations applicable in the EU, USA, Canada and other markets in which we operate.

 

Marketing and PR

We continue to ensure our marketing programmes are both fresh and innovative, focused on both customer loyalty and showcasing our products to new potential consumers, with a particular emphasis on social media using brand ambassadors, influencers and make-up artists. Our online loyalty programme, initiated in 2020, continues to help retain customers and increase basket size.

Strategy

On an annual basis the board reviews and appropriately adapts its three-year strategic plan for the business based on market data, experience and the Group's aims. This is targeted by year, measured monitored and reviewed as part of the board's on-going business throughout the year. The strategic plan has been updated for 2023, forming the basis of the Group's development through to 2025. The plan is designed to drive shareholder value and has defined targets for sales, EBITDA, earnings per share and cash generation with a particular emphasis on driving incremental EBITDA growth.

The strategic plan comprises six key pillars:

· Develop and build the Group's brands and provide new product development that meets changing trend and consumer needs

The Group ensures that everybody within the business has crystal clarity of the positioning of the Group's portfolio of brands; that there is a clear brand hierarchy; non-core brands and products have been eliminated; that close-out continues to reduce as a proportion of sales; and the Group delivers quality new product development, category extensions where appropriate to the brand and gifting sets that are on-trend and meets the consumers changing needs.

· Develop and nurture the current core business

A major objective of the Group is to continue to develop and grow the presence of the Warpaint brands beyond their existing customer base. There is still, however, significant potential to be realised and further distribution gains in the current customer base and the Group is committed to ensuring this potential is maximised. The Group is focused on ensuring there is a clarity of product offering to each customer segment and to supporting its customers with relevant new products; by using appropriate marketing and innovative merchandising solution to draw consumers into customer stores; and by enhancing the customer offer by cross selling the Group's brands and category extensions for example accessories, body mists, gifting and skin care where appropriate. 

· Grow market share in the UK

The business continues to focus on increasing the presence of the Group's brands in channels that our consumers shop in, to increase accessibility and drive profitable market share growth. As a result of this strategy, the Group has successfully launched the W7 brand into Tesco, where distribution gains across all store formats continue to be driven, into Boots, and the Technic and Body Collection brands into wilko. It continues to have active discussions with other major retailers who are currently in channels that the Group is yet to materially supply to and expanding the UK customer base is a key focus of management. For example a trail successfully activated in 20 New Look stores in the fashion retail sector in Autumn 2022, will be rolled out to a further 200 New Look stores in mid 2023. This is a particular focus as the business continues to capitalise on consumers and retailers across all sectors alike who are increasingly looking to provide quality products to their customers at affordable prices. 

· Grow market share in the USA and China

The USA and China continue to provide a major growth opportunity for the Group. In the USA, the Group has established distributor and agency channels and is using employees to directly sell to retailers. A compelling core product range for the USA has been established with minimum margin requirements. The business is focused on targeted customer initiatives that have gained both gifting and all year around listings with major retailers across key channels. In China the Group conducts business locally through its Chinese subsidiary company. We are also continuing to register products for sale in China in order to grow our total offering and increase sales. This has led to the development of relationships with distributors in the region who have the capability to drive sales of the W7 brand via a W7 storefront on on-line marketplaces.

· Develop the online/e-commerce strategy for brand development and profitable sales

The Group aims to grow and maximise profitable sales across the Group's on-line sales channels. As well as continuing to sell on the businesses' own websites and developing its own consumer community, plans continue to be executed to develop sales across Amazon platforms. W7 stores have been launched in the UK, USA and key European markets on Amazon and are fulfilled by Amazon. Further on-line sales platforms and geographies continue to be evaluated and, where profitable opportunities are identified, launched over the course of the three year plan. The first of these is planned to be Japan in 2023. The Group continues to develop and build its brands by utilising brand ambassadors, influencers and make-up artists to engage actively with its target audience. The Group wants to ensure that consumers are adequately inspired and educated on how the Group's products can be used to experiment and achieve different looks. Developing the social media strategy also directly impacts the Group's online sales strategy.

· Develop and implement appropriate strategies that ensure Warpaint reduces its impact on the environment

The Group recognises consumers', customers' and our own requirement to reduce our environmental impact. The business has already identified and implemented a number of initiatives to reduce our environmental footprint via reduced shipping and road mileage; removing plastics where possible from packaging and improving recyclability; removing parabens from ingredients; and ensuring all products are manufactured cruelty free. Further initiatives have been identified and targeted with the aim of being implemented across the course of the three year plan. Further information is contained within the ESG section of this report.

Brands

In 2020 we undertook a review of all our brands, and since then the Group has concentrated on its core W7, Technic, Body Collection, Man'stuff and Chit Chat brands, being those with the most compelling market position.

Customers & Geographies

The largest markets for sales of our Group brands are in the UK and continental Europe. In 2022 our top ten customers represented 60% of revenues (2021: 57%). Group sales are made in 43 countries (2021: 43).

UK

The UK accounted for 43% Group sales in 2022 (2021: 51%), with UK sales increasing by 9% to £27.6 million (2021: £25.3 million). Sales growth in the UK was seen by both our lead brand W7, which increased by 7%, and the Technic brands, which increased by 24%. UK sales in Q1 2023 are 23% ahead of the same period in 2022.

The top ten UK Group customers accounted for 74% of UK sales in 2022 (2021: 71%). Particularly strong growth was seen during the year with Asda and Bodycare. Additionally, after an initial trial of W7 product in 20 New Look stores, the Group is now rolling out W7 product to a further 200 New Look stores during 2023. We are also in continued talks with Tesco to increase the W7 offering in their stores and anticipate further expansion across their estate this year.

Europe

In 2022 Group sales in Europe increased by 56% to £28.1 million, compared to £18.0 million in the same period in 2021, making this the largest sales region for the Group, accounting for 46% of Group branded sales in 2022, and 44% of overall Group sales in 2022 (2021: 36%). Sales for the Group's brands into Europe are mainly to Denmark, Spain, France and Sweden and during the year strong growth was seen particularly through increased sales to certain existing European customers as the number of these customers stores served by the Group was expanded. Group sales in Europe in Q1 2023 continued to accelerate and were 41% ahead of the same period in 2022.

USA

USA sales, in sterling terms, increased by 79% in 2022 to £5.3 million (2021: £3.0 million) and grew by 55% in US dollar terms. This equated to 8% of overall 2022 Group sales (2021: 6%).  In the US 97% of sales in 2022 (2021 89%) were from the sale of the Group's brands as minimal close-out activity was undertaken, in line with the Group's strategy to focus on its own brands.  

A good performance was seen from the Group's major customers in the USA, including CVS, Five Below, Macys Backstage, Marshalls, and TJ Maxx.  Six significant new accounts were added in the US in 2022, including with CVS, where a large Christmas 2022 order was delivered, and with H-E-B stores, a Texas based supermarket group, where an extensive range of nail polish was launched in 280 of their stores in the last quarter of the year. From July 2023 it is expected that a full range of 120 W7 colour cosmetics products will be stocked in 80 of the H-E-B stores.

A further agreement was reached to launch a range of 60 W7 cosmetic products in 190 CVS BIRL stores, from January 2023, and initial sales have been ahead of expectations. Additional orders have also been received from Nordstrom Rack and Sallys in the US, where a significant order has been received for delivery in July 2023. US sales in Q1 2023 are 61% ahead of the same period in 2022.

Rest of the World

Sales in the rest of the world decreased by 16% from £3.7 million in 2021 to £3.1 million in 2022 accounting for 5% of overall Group sales (2021: 7%). The reduction in sales was primarily as a result of the timing of sales orders in Australia, which is a key country for Warpaint in the rest of the world region. The focus in the rest of the world region continues to be on Australia, China and other countries where profitable sales in appropriate volumes can be made.

The Group has no suppliers in either Russia or Ukraine, and no significant historic sales to either country.

People - Cost of Living Bonus

The board recognises that we are living in difficult times, with inflationary pressures causing significant increases in the cost of living. To provide some assistance with these increased living costs and to acknowledge the exceptional efforts in a record period for the Group, all of the Group's 122 employees (which excludes the board members) were awarded a payment of £1,000 over and above their normal remuneration in October 2022.

Summary and Outlook

I am delighted with the Group's performance in 2022. We have enjoyed strong growth in sales and that these sales have been achieved at a significantly improved gross margin, despite supply side inflationary pressures, is a significant achievement. To date the Group has been largely able to mitigate supply side inflation with a price rise implemented in January 2022, sourcing product from new factories, and new product development, all of which are ongoing. In 2023, together with significantly reduced transport costs, we remain confident that margins can be maintained.

Whilst we continue to experience good growth in the UK, I am particularly pleased with the growth we are seeing in continental Europe and the US. We have put in place a robust supply chain and distribution network to ensure that we are able to supply our retailer's outlets on time with the product that their customers are demanding. The Group is also in active discussions with new major retailers globally and with certain existing customers regarding expansion of the range of the Group's products stocked.

Online sales also continue to grow and the focus remains on ensuring they can deliver a similar margin to the Group's sales through traditional physical outlets. In 2023, the Group will launch online sales in Japan through Amazon, a similar model to that successfully deployed in the US.

Trading in 2023 has started strongly with a record first quarter. Sales for the first three months of 2023 are approximately 40% ahead of the same period in 2022, with sales increases seen across all of the Group's brands, both in stores and online, and at an improved gross margin to that achieved in the full year 2022.

We will update further on our progress later in the year and with significant opportunities for further growth, both already secured with our existing retailers and in discussion with additional major retailers globally, I am confident that the Group will continue to perform well for the remainder of the year and beyond.

Sam Bazini

Chief Executive Officer

25 April 2023

CHIEF FINANCIAL OFFICER'S REVIEW

2022 was a record year for the Group, with strong growth in sales, margins and profit before tax.  Group revenue increased in the year by 28% and adjusted profit before tax increased by 46%. Gross margin improved in the year by 2.6% to 36.4%. This is the second year running that gross margin has improved despite some increased costs in the supply chain. The Group continues its strategy of building the W7 and Technic brands in the UK and internationally, and we remain focused on margin, being debt free, and generating cash.

The Group monitors its performance using a number of key performance indicators which are agreed and monitored by the board. Headline results, shown below, represent the performance comparisons between the consolidated statements of income for the years ended 31 December 2021 and 31 December 2022.

Revenue

Group revenue for the year increased by 28.1% from £50.0 million in 2021 to £64.1 million in 2022. 

Company branded sales were £57.7 million in 2022 (2021: £44.4 million). Our W7 brand had sales in the year of £35.0 million (2021: £25.9 million). Our Technic brand contributed sales of £22.7 million (2021: £18.5 million).

Our Retra subsidiary business had sales of retailer own brand white label cosmetics of £2.6 million in the year (2021: £1.1 million). The white label business is traditionally cost competitive and Retra chooses which projects to undertake based on commercial viability, in particular margin.

The close-out business revenue reduced by 15.8% from £4.5 million in 2021 to £3.8 million in 2022 as the Group, in line with its strategy, continued to reduce its focus on close-out opportunities.

In the UK sales increased by 8.8% to £27.6 million (2021: £25.3 million). Internationally, revenue increased 47.8% from £24.7 million in 2021, to £36.5 million 2022. In Europe Group sales increased by 55.6% to £28.1 million (2021: £18.0 million). In the rest of the world Group sales decreased by 16.0% to £3.1 million (2021: £3.7 million). In the US Group sales increased by 78.8% to £5.3 million (2021: £3.0 million).

E-commerce sales continued to grow in the year and now represent 4.3% / £2.8 million of group revenue (2021: 2.7% / £1.3 million).

Product Gross Margin

Gross margin was 36.4% for the year compared to 33.8% in 2021. Our management teams across the Group were swift to recognise and navigate cost headwinds that started in 2021. New product development, sourcing product from new factories, and an inflationary price increase to customers at the start of the year, have all helped achieve a significant gross margin improvement in 2022.

 

The cost of freight from the Far East is a significant cost of goods throughout the Group. Container freight rates which increased dramatically in 2021, started to slowly fall in 2022 by on average 20%. As we end Q1 2023 freight rates have fallen from record highs in 2021 to now record lows in 2023, which are currently 80% lower year on year and, if maintained, will help to improve our gross margin in the current year.

 

We remain focused on improving gross margin where possible in all our businesses and are making good use of our Hong Kong buying office to ensure this happens. To counter currency pressure, we continue to move production to new factories of equal quality to retain or improve margin and have a natural hedge from our US dollar revenue which is growing.

 

At 31 December 2021 options were in place for the purchase of US$27 million at US$1.3849/£; this has helped to protect our margin in the turbulent foreign exchange markets. Towards the end of 2022 we purchased various options to help protect our gross margin in 2023, these included traditional forward purchase foreign exchange options for US$3 million at US$1.2146, and more complex forward purchase foreign exchange options which will deliver a minimum of $18 million to a maximum of $36 million at an average rate for 2023 of $1.1984/£. Since the start of this year we have purchased more forward options to help protect our gross margin in 2023.

 

The currency options we have for the current year, the falling container rates, new product development, sourcing, and growing sales in the USA, will all help to protect our margin in 2023.

 

Operating Expenses

Total operating expenses before exceptional items, amortisation costs, depreciation, foreign exchange movements and share based payments, grew more slowly than sales, increasing by 24.1% to £11.4 million in the year (2021: £9.2 million). Operating costs as a percentage of sales reduced from 18.4% to 17.8%.

The overall increase of £2.2 million in the year was necessary to support the growth of the business.

Increased costs amounted to £2.3 million and were made up of increases in wages and salaries, office costs, travel costs, the spend on PR and marketing as e-commerce sales continue to grow, professional fees and the cost of a larger sales team based in the US.

Included in the increase to wages and salaries is a one off cost of living crisis payment of £0.1 million to all of the Groups employees excluding board members.

The increase in office costs includes an extra £0.06 million of utility charges. At current rates utility costs are expected to increase in 2023 by a further £0.08 million.

There was a decrease in the charge for bad debts of £0.1 million.

Warpaint remains a business with most operating expenses relatively fixed and evenly spread across the whole year. We continue to monitor and examine significant costs to ensure they are controlled and strive to reduce them. In addition, the increased scale of the business has given the Group increased buying power.

Adjusted EBITDA

The board considers Adjusted EBITDA (adjusted for foreign exchange movements, share based payments and exceptional items) a key measure of the performance of the Group and one that is more closely aligned to the success of the business. Adjusted EBITDA for the year was £11.9 million (2021: £7.7 million).

Profit Before Tax

Group profit before tax for the year was £7.7 million (2021: £3.7 million). The material changes in profitability between 2022 and 2021 were:

Effect on Profit

Sales volume growth

£4.7 million

Margin growth

£1.7 million

Increase in operating expenses

(£2.2) million

FX gain in 2022 £0.1 million (2021: Gain £0.6 million)

(£0.5) million

Increase in finance costs

(£0.2) million

Increase in depreciation and amortisation of right-of-use assets

(£0.3) million

Decrease in the charge for amortisation costs on acquisition*

£0.4 million

Decrease in exceptional costs

£0.4 million

 

*Acquisition costs are amortised over 5 years. The reduction in 2022 reflects the end of the write off period since the purchase of Retra in November 2017.

Exceptional Items

Exceptional items include £nil of staff restructuring and voluntary redundancy costs (2021: £0.03 million), £nil of non-recurring legal costs (2021: £0.18 million), and £0.15 million for content use and associated legal fees (2021: £0.37 million).

During the year the Group agreed a settlement regarding a dispute with a third party relating to the historic use of content on the Group's social media platforms in the period from 2018 through to early 2021. The total settlement including associated legal costs was £0.52 million, of which £0.37 million was provided for in the year to 31 December 2021. The payment and the restriction of content use will not affect the ongoing operations of the Group's businesses.

Tax

 

The tax rate for the Group for 2022 was 19% compared to the UK corporation tax standard rate of 19% for the year. Since the acquisition of LMS, the Group is exposed to tax in the USA at an effective rate of approximately 25% and in other jurisdictions the Group operates cost centres, but these are not materially exposed to changes in tax rates.

Earnings Per Share

The statutory basic and diluted earnings per share was 8.14p and 8.11p respectively in 2022 (2021: 3.69p and 3.68p).

The adjusted basic and diluted earnings per share before exceptional items, amortisation costs and share based payments was 11.19p and 11.15p respectively in 2022 (2021: 7.80p and 7.79p).

Dividends

The board is recommending a final dividend for 2022 of 4.5 pence per share, making a total dividend for the year of 7.1 pence per share of which 2.6 pence per share was paid on 25 November 2022 (2021: total dividend of 6.0 pence per share, of which the interim dividend was 2.5 pence per share and the final dividend was 3.5 pence per share). The dividend for the year was covered 1.6 times by adjusted earnings per share.

Cash Flow and Cash Position

Net cash flow generated from operating activities was £8.4 million (2021: £5.1 million). The Group's cash balance increased by £1.8 million to £5.9 million in 2022 (2021: £4.1 million). The cash generated was principally used to make dividend payments in the year.

We expect capital expenditure requirements of the Group to remain low, however as part of our strategy to grow market share in the UK and US there will be occasions where investment in store furniture is required to secure that business. 

In 2022 £0.29 million was spent on store furniture for Tesco, Boots and wilko (2021: £0.49 million), £0.42 million was spent on warehouse improvements, new forklifts and racking (2021: £0.04 million), £0.09 million was spent on new computer software and equipment (2021: £0.02 million), and £0.03 million was spent on other general office fixtures and fittings and plant upgrades (2021: £0.04 million).

Given the growth of the Group in the last two years it is necessary and prudent to have bank facilities available to it to help fund day to day working capital requirements as the Group continues to grow. Accordingly the Group maintains a £9.5 million invoice and stock finance facility which is used to help fund imports in our gifting business during the peak season. At the year end no invoice and stock finance remained outstanding (2021: £nil million). In addition, in February 2023 the Group added a new "general purpose" facility of £3 million. These facilities, together with the Groups positive cash generation and the growing cash balance held, ensure that future growth can be funded.

 

LTIP, EMI & CSOP Share Options

On 17 October 2022 CSOP share options were granted over a total of 20,000 ordinary shares of 25p each in the Company under the Warpaint London plc Company Share Option Plan. The options provide the right to acquire 20,000 ordinary shares at an exercise price of 132.5p per ordinary share.

On 2 March 2022 EMI (non-qualifying) share options were granted over a total of 200,000 ordinary shares of 25p each in the Company under the Warpaint London plc Enterprise Management Incentive Scheme. The options provide the right to acquire 200,000 ordinary shares at an exercise price of 127.5p per ordinary share.

The LTIP, EMI & CSOP share options had an immaterial dilutive impact on earnings per share in the period. The share-based payment charge of the LTIP, EMI and CSOP share options for the year was £0.19 million (2021: £0.18 million) and has been taken to the share option reserve.

Balance Sheet

Inventory was £0.6 million higher at the year end at £18.7 million (2021: £18.1 million). The rise in inventory is a function of growth in the business and to ensure delivery disruption is avoided for our customers. One of the Group's unique selling propositions is that it can deliver a full range of colour cosmetics to our customers, in good time all year round. Having appropriate inventory levels is vital to providing that service. The provision for old and slow inventory was £0.37 million, 1.9% at the year end (2021: £0.52 million, 2.8%). Across the Group we have worked hard in the year to sell through older stock lines, allowing for our provision for old and slow inventory to fall 0.9% in percentage terms. Our Group policy is to provide for 50% of the cost of perishable items that are over two years old. However, we remain comforted by the fact that many such items in the normal course of business are eventually sold through our close-out division without a loss to the Group. 

Trade receivables are monitored by management to ensure collection is made to terms, to reduce the risk of bad debt and to control debtor days, which have improved on the prior year. At the year end trade receivables, excluding other receivables, were £9.9 million (2021: £8.8 million), the increase on 2021 due to the rise in sales year on year. The provision for bad and doubtful debts carried forward at the year end was £0.07 million, 0.7% of gross trade receivables (2021: £0.07 million, 0.8%).

The Group has no borrowings or lease liabilities outstanding at the year end (2021: £nil), apart from those associated with right-of-use assets as directed by IFRS 16 (see below). The Group was therefore debt free at the year end. 

Working capital increased by £4.1 million in the year, to £30.3 million. The main components were an increase in inventory of £0.6 million, an increase in trade and other receivables of £1.4 million, an increase in cash at the year end of £1.8 million, and a decrease in trade and other payables of £0.3 million.

Free cash flow (cash from operating activities less capital expenditure) remained strong at £7.6 million (2021: £4.5 million).

 

The Group's balance sheet remains in a very healthy position. Net assets totalled £37.8 million at 31 December 2022, an increase of £1.7 million from 2021. Most of the balance sheet is made up of liquid assets of inventory, trade receivables and cash. Included in the balance sheet is £7.3 million of goodwill (2021: £7.3 million) and £0.3 million of intangible fixed assets (2021: £2.3 million) arising from acquisition accounting. As at the year end cash totalled £5.9 million (31 December 2021: £4.1 million).

Goodwill represents the excess of consideration over the fair value of the Group's share of the net identifiable assets of the acquired business / cash generating units at the date of acquisition. The carrying value at 31 December 2022 of £7.3 million included Treasured Scents Limited (Close-out business) £0.5 million, Retra Holdings Limited £6.2 million and Marvin Leeds Marketing Services, Inc. £0.6 million. Management have performed the required annual impairment review at 31 December 2022 and have concluded that no impairment is indicated for Treasured Scents Limited, Retra Holdings Limited or Marvin Leeds Marketing Services, Inc. as the recoverable amount exceeds the carrying value.

 

The balance sheet also includes £5.7 million of right-of-use assets, this is the inclusion of the Group leasehold properties, now recognised as right-of-use assets as directed by IFRS 16. An equivalent lease liability is included of £5.9 million at the balance sheet date.

 

Foreign Exchange

The Group imports most of its finished goods from China paid for in US dollars, which are purchased throughout the year at spot as needed, or by taking forward purchase foreign exchange options when rates are deemed favourable, and with consideration for the budget rate set by the board for the year. Similarly, foreign exchange options are taken to sell forward our expected Euro income in the year to ensure our sales margin is protected.

We started 2022 with options in place for the purchase of US$27 million at US$1.3849, and the sale of €3.9 million at €1.1558. During 2022 when currency rates were favourable, we purchased additional US dollar foreign exchange options and spot rate amounts to cover our total US dollar requirement for the year.

In addition, towards the end of 2022 we purchased various options to help protect our gross margin in 2023, these included traditional forward purchase foreign exchange options for US$3 million at US$1.2146, and more complex forward purchase foreign exchange options known as Window Barrier Accruals and Counter TARFs which will deliver a minimum of $18 million to a maximum of $36 million (depending on the dollar rate at maturity of each option) at an average rate for 2023 of $1.1984/£. We also sold €3.8 million at €1.1340. All of these options were outstanding at 31 December 2022.

The Group has a natural hedge from sales to the US which are entirely in US dollars, in 2022 these sales were $6.32 million (2021: $4.08 million).

Together with sourcing product from new factories where it makes commercial sense to do so, new product development, and by buying US dollars when rates are favourable, we are able to mitigate the effect of a strong US dollar against sterling.

 

Section 172(1) Statement

The directors are well aware of their duty under section 172 of the Companies Act 2006 to act in the way which they consider, in good faith, would be most likely to promote the success of the Company for the benefit of its members as a whole, and in doing so have regard (amongst other matters) to:

· the likely consequences of any decision in the long term;

· the interests of the Company's employees;

· the need to foster the Company's business relationships with suppliers, customers and others;

· the impact of the Company's operations on the community and the environment;

· the desirability of the Company maintaining a reputation for high standards of business conduct, and

· the need to act fairly as between members of the Company

(the "Section 172 (1) Matters").

Induction materials provided on appointment include an explanation of directors' duties, and the board is regularly reminded of the Section 172(1) Matters, as a board meeting agenda item.

Further information on how the directors have had regard to the Section 172(1) Matters can be found in the Stakeholder Engagement and Section 172 Report. This information forms part of the strategic report and has been approved for issue by the board on 25 April 2023.

Neil RodolChief Financial Officer

25 April 2023

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2022

 

Year ended 31 December

2022

2021

Note

£'000

£'000

 

 

Revenue

2

64,058

50,003

 

Cost of sales

2

(40,724)

(33,095)

 

Gross profit

 

23,334

16,908

 

 

Administrative expenses

3,4

(15,367)

(13,095)

 

Analysed as:

 

Adjusted profit from operations1

10,307

6,970

 

Amortisation

3,9

(1,995)

(2,394)

Exceptional items

3

(152)

(586)

Share based payments

21

(193)

(177)

Profit from operations

 

7,967

3,813

 

Net finance cost

5

(277)

(88)

 

Profit before tax

 

7,690

3,725

 

 

Tax expense

6

(1,440)

(895)

 

Profit for the year attributable to equity holders of the parent company

6,250

2,830

 

Other comprehensive loss:

Item that will or may be reclassified to profit or loss:

Exchange loss on translation of foreign subsidiary

(135)

(4)

Total comprehensive income attributable to equity holders of the parent company , net of tax

6,115

2,826

Basic earnings per share (pence)

26

8.14

3.69

Diluted earnings per share (pence)

26

8.11

3.68

 

Note 1 - Adjusted profit from operations is calculated as earnings before interest, taxation, amortisation of intangible assets, share based payments and exceptional items.

The notes form part of these financial statements.

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2022

 

 

As at 31 December

 

2022

2021

Note

£'000

£'000

Non-current assets

Goodwill

8

7,274

7,274

Intangibles

9

277

2,260

Property, plant, and equipment

10

1,432

1,385

Right-of-use assets

11

5,659

3,073

Deferred tax assets

17

429

500

 

Total non-current assets

15,071

14,492

 

Current assets

Inventories

12

18,715

18,139

Trade and other receivables

13

11,693

10,322

Cash and cash equivalents

14

5,865

4,072

Derivative financial instruments

23

8

545

 

Total current assets

 

36,281

33,078

 

Total assets

 

51,352

47,570

 

 

Current liabilities

 

Trade and other payables

15

(5,988)

(6,293)

Borrowings and lease liabilities

16

(1,015)

(610)

Corporation tax liability

 

(943)

(1,050)

Derivative financial instruments

23

(600)

-

Provisions

 

-

(370)

 

Total current liabilities

 

(8,546)

(8,323)

 

 

Non-current liabilities

 

Borrowings and lease liabilities

16

(4,847)

(2,537)

Deferred tax liabilities

17

(180)

(557)

 

 

Total non-current liabilities

(5,027)

(3,094)

Total liabilities

(13,573)

(11,417)

NET ASSETS

37,779

36,153

 

 

The notes form part of these financial statements.

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2022

 

 

2022

2021

 

£'000

£'000

Equities

 

 

Share capital

19

19,188

19,188

Share premium

19,360

19,360

Merger reserve

(16,100)

(16,100)

Foreign exchange reserve

 

(50)

85

Share option reserves

20

2,003

1,810

Retained earnings

13,378

11,810

TOTAL EQUITY

37,779

36,153

 

 

The financial statements of Warpaint London plc were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

 

Neil Rodol

Chief Financial Officer

 

Date: 25 April 2023

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2022

 

 

 

 

Share Capital

Share Premium

Merger Reserve

Foreign exchange reserve

Share option reserve

Retained Earnings

Total Equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 1 January 2021

19,187

19,359

(16,100)

89

1,633

13,202

37,370

Comprehensive income/(loss) for the year

Equity shares issued

1

1

-

-

-

-

2

On translation of foreign subsidiary

-

-

-

(4)

-

-

(4)

Profit for the year

-

-

-

-

-

2,830

2,830

Total comprehensive income for the year

1

1

-

(4)

-

2,830

2,828

Transactions with owners

Share based payment charge

-

-

-

-

177

-

177

Dividends paid

-

-

-

-

-

(4,222)

(4,222)

 

Total transactions with owners

-

-

-

-

177

(4,222)

(4,045)

 

As at 31 December 2021

19,188

19,360

(16,100)

85

1,810

11,810

36,153

Comprehensive Income/(loss) for the year

Equity shares issued

-

-

-

-

-

-

-

On translation of foreign subsidiary

-

-

-

(135)

-

-

(135)

Profit for the year

-

-

-

-

-

6,250

6,250

Total comprehensive income for the year

-

-

-

(135)

-

6,250

6,115

Transactions with owners

Share based payment charge

-

-

-

-

193

-

193

Dividends paid

-

-

-

-

-

(4,682)

(4,682)

Total transactions with owners

-

-

-

-

193

(4,682)

(4,489)

 

 

 

 

 

 

 

 

 

As at 31 December 2022

19,188

19,360

(16,100)

(50)

2,003

13,378

37,779

 

 

The notes form part of these financial statements.

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2022

 

Year ended 31 December

 

2022

2021

Note

£'000

£'000

Operating activities

Profit before tax

7,690

3,725

Finance expense

5

278

90

Amortisation of intangible assets

9

1,995

2,394

Depreciation of property, plant, and equipment

10

761

649

Depreciation on right of use assets

11

965

690

Loss on disposal of property, plant, and equipment

1

-

Share based payments

21

193

177

Increase in trade and other receivables

 

(1,370)

(1,135)

Increase in inventories

12

(576)

(3,726)

(Decrease)/increase in trade and other payables

(981)

3,541

Fair value loss/(gain) on derivative financial instruments

1,139

(905)

Other non-cash adjustments

17

-

(84)

Foreign exchange translation differences

(117)

(4)

Cash generated from operations

 

9,978

5,412

Tax paid

(1,546)

(325)

Net cash flows from operating activities

 

8,432

5,087

 

 

 

 

Investing activities

Purchase of intangible assets

9

(12)

(3)

Purchase of property, plant, and equipment

10

(831)

(596)

Net cash used in investing activities

 

(843)

(599)

 

 

 

 

Financing activities

Repayment of borrowings

16

-

(48)

Lease payments

16

(836)

(933)

Proceeds from issued share capital

 

-

2

Interest paid

5

(278)

(90)

Dividends

18

(4,682)

(4,222)

Net cash used in financing activities

 

(5,796)

(5,291)

 

Net increase/(decrease) in cash and cash equivalents

1,793

(803)

Cash and cash equivalents at beginning of period

4,072

4,875

Cash and cash equivalents at end of period

14

5,865

4,072

 

Cash and cash equivalents consist of:

Cash and cash equivalents

14

5,865

4,072

 

5,865

4,072

The notes on pages 70 to 121 form part of these financial statements.

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

AS AT ENDED 31 DECEMBER 2022

 

1. Significant accounting policies

 

Basis of preparation

The financial statements of Warpaint London PLCPLC (the "Company" or "Warpaint") and its subsidiaries (together the "Group") for the year ended 31 December 2022 were authorised for issue by the board of directors on 25th April 2023.

 

Warpaint London PLCPLC is a public limited Company incorporated and registered in England and Wales. Its registered office is Units B&C, Orbital Forty-Six, The Ridgeway Trading Estate, Iver, Buckinghamshire, SL0 9HW.

 

The Group's financial statements have been prepared in accordance in accordance UK adopted international accounting standards and in conformity with the requirements of the Companies Act. The functional currency of the parent and its subsidiaries is pounds sterling because that is the currency of the primary economic environment in which the Group operates. The financial statements are also presented in pounds sterling. All values are rounded to the nearest thousand (£'000) except where otherwise indicated.

 

The annual financial statements have been prepared on the historical cost basis, except for certain financial assets and liabilities which are carried at fair value or amortised cost as appropriate.

 

The preparation of financial statements in accordance with UK adopted international accounting standards requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Although these estimates are based on management's best knowledge of current events and actions, actual results ultimately may differ from those estimates. The principal accounting policies adopted are set out below.

 

Basis of consolidation

Where the company has control over an investee, it is classified as a subsidiary. The company controls an investee if all three of the following elements are present: power over the investee, exposure to variable returns from the investee, and the ability of the investor to use its power to affect those variable returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.

 

The consolidated financial statements present the results of the company and its subsidiaries as if they formed a single entity. Intercompany transactions and balances between group companies are therefore eliminated in full. All subsidiaries have a reporting date of December.

 

The consolidated financial statements incorporate the results of business combinations using the acquisition method. In the statement of financial position, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the consolidated statement of comprehensive income from the date on which control is obtained. They are deconsolidated from the date on which control ceases.

 

On consolidation, the results of overseas operations are translated into pounds sterling at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations, including goodwill arising on the acquisition of those operations, are translated at the rate ruling at the reporting date. Exchange differences arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in other comprehensive income and accumulated in the foreign exchange reserve.

 

Exchange differences recognised profit or loss in Group entities' separate financial statements on the translation of long-term monetary items forming part of the Group's net investment in the overseas operation concerned are reclassified to other comprehensive income and accumulated in the foreign exchange reserve on consolidation.

 

On disposal of a foreign operation, the cumulative exchange differences recognised in the foreign exchange reserve relating to that operation up to the date of disposal are transferred to the consolidated statement of comprehensive income as part of the profit or loss on disposal.

 

Going concern

 

The Directors have concluded that it is reasonable to adopt a going concern basis in preparing the financial statements. This is based on a reasonable expectation that the Group has adequate resources to continue in operational existence for at least twelve months from the date of signing of these accounts. The Group made a statutory profit of £6.1 million in the year to 31 December 2022 (2021: £2.8 million) and had net current assets of £27.7 million at 31 December 2022 (2021: £24.8 million).

The Group occasionally makes use in its Retra Holdings Limited ("Retra") subsidiary of a £6.0 million bank facility that can be used for confidential invoice discounting, the facility renews each year at the end of September. Retra also have a £3.5 million bank facility that can be used for stock finance, which is used if needed during the peak gift buying season, the facility renews each year at the end of November. In addition, the Group have a £3.0 million general purpose bank facility in its Warpaint Cosmetics (2014) Limited ("Warpaint Cosmetics") subsidiary which was agreed in January 2023. This facility will renew annually and was put in place to support the continued growth of the business. As at the year end £nil of the bank facilities were utilised and the Directors expect that in 2023 the facilities will only be used to modest levels well within the facility limits, to support the day to day working capital of the business. At the 31 March 2023 the company had cash of £8.6 million, no debt and had used £nil of its bank facilities.

The Directors have prepared forecasts covering the period to December 2024, built from the detailed Board-approved budget for 2023. The forecasts include a number of assumptions in relation to varying levels of sales revenue. Whilst the Group's trading and cash flow forecasts have been prepared using current trading assumptions, the operating environment presents a number of challenges which could negatively impact the actual performance achieved. These challenges include, but are not limited to, achieving forecast levels of sales and order intake, the impact on customer confidence as a result of general economic conditions and leaving the European Union, achieving forecast margin improvements, supply side price inflation, increases in freight costs, and the director's ability to implement cost saving initiatives in areas of discretionary spend where required. 

The Group's cash flow forecasts and projections, taking account of reasonable and possible changes in trading performance, offset by mitigating actions within the control of management including reductions in areas of discretionary spend, show that the Group will be able to operate comfortably through to the end of December 2024, and in Retra and Warpaint Cosmetics within the level of their own bank facility.

In preparing this analysis, a number of scenarios were modelled with the benefit of experience. The scenarios modelled were all based on varying levels of sales revenue, including one that assumes no growth for 2023 and 2024 as a reasonable downside scenario, and more extreme falls in revenue of up to 30% in both years as a worst-case scenario. In each scenario, mitigating actions within the control of management have been modelled. Under each of the scenarios modelled, the Group has sufficient cash to meet its liabilities as they fall due and consequently, the directors believe that the Group has sufficient financial strength to withstand the possible disruption to its activities.

Based on the above indications the directors believe that it remains appropriate to prepare the financial statements on a going concern basis.

Revenue Recognition

 

Performance obligations and timing of revenue recognition

The Group's revenue is derived from selling goods with revenue recognised at a point in time when control of the goods has transferred to the customer. This is generally when the goods are delivered to the customer. However, for export sales, control might also be transferred when delivered either to the port of departure or port of arrival, depending on the specific terms of the contract with a customer. There is limited judgement needed in identifying the point control passes: once physical delivery of the products to the agreed location has occurred, the group no longer has physical possession, usually will have a present right to payment (as a single payment on delivery) and retains none of the significant risks and rewards of the goods in question.

 

UK sales are recognised and invoiced to the customer once the goods have been delivered to the customer. Overseas sales are recognised and invoiced to the customer once the goods have been delivered to the customer or collected by the customer from the Group's warehouse according to the terms of sale. Online sales are recognised and invoiced to the customer once the goods have been delivered to the customer.

 

Customer loyalty

The Group operates a loyalty reward scheme for 'digital' customers where points are earned for products purchased online, with 10 points equivalent to £1. The Group accounts for loyalty points when redeemed as a sales discount on the sales transaction. A sales discount provision is recognised in the accounts in relation to points issued but not yet redeemed. When estimating this provision, the Group considers the likelihood that the customer will redeem the points. At the year-end there were 6.5 million points yet to be redeemed, leading to a provision of £32,471 (2021: 2.8 million points leading to a provision of £14,000).

 

 Under IFRS 15, volume rebates and early settlement discounts represent variable consideration and is estimated and recognised as a reduction to revenue as performance obligations are satisfied. Management recognises revenue based on the amount of estimated rebate to the extent that revenue is highly probably of not reversing. Management monitors this estimate at each reporting date and adjusts it as necessary.

 

Determining the transaction price

Most of the group's revenue is derived from fixed price contracts and therefore the amount of revenue to be earned from each contract is determined by reference to those fixed prices. Exceptions are as follows:

 

·

Some contracts provide customers with a limited right of return. These relate predominantly, but not exclusively, to online sales direct to consumers and sales made to certain large retailers. Historical experience enables the group to estimate reliably the value of goods that will be returned and restrict the amount of revenue that is recognised such that it is highly probable that there will not be a reversal of previously recognised revenue when goods are returned.

·

Variable consideration relating to volume rebates has been considered in estimating revenue in order that it is highly probable that there will not be a future reversal in the amount of revenue recognised when the amount of volume rebates has been determined.

 

Allocating amounts to performance obligations

For most contracts, there is a fixed unit price for each product sold, with reductions given for bulk orders placed at a specific time. Therefore, there is no judgement involved in allocating the contract price to each unit ordered in such contracts (it is the total contract price divided by the number of units ordered). Where a customer orders more than one product line, the Group is able to determine the split of the total contract price between each product line by reference to each product's standalone selling prices (all product lines are capable of being, and are, sold separately).

 

Practical Exemptions

The group has taken advantage of the practical exemptions:

·

not to account for significant financing components where the time difference between receiving consideration and transferring control of goods (or services) to its customer is one year or less; and

·

expense the incremental costs of obtaining a contract when the amortisation period of the asset otherwise recognised would have been one year or less.

 

Expenditure and provisions

Expenditure is recognised in respect of goods and services received when supplied in accordance with contractual terms. Provision is made when an obligation exists relating to a past event and where the amount of the obligation can be reliably estimated.

 

Retirement Benefits: Defined contribution schemes

Contributions to defined contribution schemes are charged to the consolidated statement of comprehensive income in the year to which they relate.

Exceptional items and Alternative Performance Measures

Exceptional items which have been disclosed separately on the face of the Consolidated Statement of Comprehensive Income in order to summarise the underlying results. Exceptional items in the current period relate to restructuring costs and legal and professional fees. Neither 'underlying profit or loss' nor 'exceptional items' are defined by IFRS however the directors believe that the disclosures presented in this manner provide a clearer presentation of the underlying financial performance of the Group.

Alternative performance measures (APM's) are used by the Board to assess the Group's performance and are applied consistently from one period to the next. They therefore provide additional useful information for shareholders on the underlying performance and position of the Group. Additionally, adjusted profit from operations is used to determine adjusted EPS which is used as a key performance indicator for the Long-Term Incentive Plan (LTIP) and the Company Share Option Scheme (CSOP). These measures are not defined by IFRS and are not intended to be a substitute for IFRS measures. The Group presents underlying profit from operations, profit before tax and EPS which are calculated as the statutory measures stated before non-underlying items, including exceptional items, amortisation of intangible assets and share-based payments where applicable.

Underlying results are used in the day-to-day management of the Group. They represent statutory measures adjusted for items which could distort the understanding of performance and comparability year on year. Non-underlying items include the amortisation of intangible assets, exceptional items and share-based payments. Exceptional items are those items which the group consider to be significant in nature and not in the normal course of business or are consistent with items that were treated as exceptional in prior periods. 

Intangible assets

 

Patents

Patents are used by the Group in order to generate future economic value through normal business operations. Patents are acquired separately and carried at cost less amortisation and impairment. The underlying assets are amortised over the period from which the Group expects to benefit, which is typically between five to ten years.

Intangible assets acquired separately

Intangible assets with finite useful lives that are acquired separately are carried at cost less accumulated amortisation and accumulated impairment losses. Amortisation is recognised on a straight-line basis over their estimated useful lives. The estimated useful life and amortisation method are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis. Intangible assets with indefinite useful lives that are acquired separately are carried at cost less accumulated impairment losses. Amortisation is provided on Licences and Website costs so as to write off the carrying value over the expected useful economic life of five years.

Intangible assets acquired in a business combination

Intangible assets acquired in a business combination and recognised separately from goodwill are initially recognised at their fair value at the acquisition date (which is regarded as their cost). Subsequent to initial recognition, intangible assets acquired in a business combination are reported at cost less accumulated amortisation and accumulated impairment losses, on the same basis as intangible assets that are acquired separately. Amortisation is provided on customer lists and brands so as to write off the carrying value over the expected useful economic life of five years. Other details of the acquisition are detailed in note 9.

Goodwill

Goodwill represents the excess of the cost of a business combination over the Group's interest in the fair value of identifiable assets, liabilities and contingent liabilities acquired.

Cost comprises the fair value of assets given, liabilities assumed, and equity instruments issued, plus the amount of any non-controlling interests in the acquiree. Contingent consideration is included in cost at its acquisition date fair value and, in the case of contingent consideration classified as a financial liability, remeasured subsequently through profit or loss.

Goodwill is considered to have an indefinite useful economic life and is capitalised as an intangible asset with any impairment in carrying value being charged to the consolidated statement of comprehensive income. Where the fair value of identifiable assets, liabilities and contingent liabilities exceed the fair value of consideration paid, the excess is credited in full to the consolidated statement of comprehensive income on the acquisition date.

Impairment of non-financial assets (excluding inventories and deferred tax assets)

Impairment tests on goodwill and other intangible assets with indefinite useful economic lives are undertaken annually at the financial year end. Other non-financial assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less costs to sell), the asset is written down accordingly.

 

Where it is not possible to estimate the recoverable amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there are separately identifiable cash flows; its cash generating units ('CGUs'). Goodwill is allocated on initial recognition to each of the Group's CGUs that are expected to benefit from a business combination that gives rise to the goodwill.

 

Impairment charges are included in profit or loss, except to the extent they reverse gains previously recognised in other comprehensive income. An impairment loss recognised for goodwill is not reversed.

 

Derecognition of intangible assets

An intangible asset is derecognised on disposal, or when no future economic benefits are expected from use or disposal. Gains or losses arising from derecognition of an intangible asset, measured as the difference between the net disposal proceeds and the carrying amount of the asset, are recognised in profit or loss when the asset is derecognised.

Property, plant and equipment

Items of property, plant and equipment are initially recognised at cost. As well as the purchase price, cost includes directly attributable costs.

 

Depreciation is provided on all items of property, plant and equipment so as to write off their carrying value over the expected useful economic lives. It is provided at the following rates:

 

Plant and machinery

-

25% reducing balance or 20% straight line

Fixtures and fittings

-

25% reducing balance or 20% straight line

Computer equipment

-

25% reducing balance or 33.33% straight line

Motor vehicles

-

20% straight line

Right-of-Use Assets

Right-of-use assets are measured at cost, which is made up of the initial measurement of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the asset at the end of the lease, less any lease incentives received.

 

The Group depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term.

The Group also assesses the right-of-use asset for impairment when such indicators exist.

The right-of-use assets are included in a separate line within non-current assets on the Consolidated Balance Sheet.

Financial assets

The Group classifies its financial assets into one of the categories discussed below, depending on the purpose for which the asset was acquired. Other than financial assets in a qualifying hedging relationship, the Group's accounting policy for each category is as follows:

Fair value through profit or loss

This category comprises in-the-money derivatives and out-of-money derivatives where the time value offsets the negative intrinsic value (see "Financial liabilities" section for out-of-money derivatives classified as liabilities). They are carried in the statement of financial position at fair value with changes in fair value recognised in the consolidated statement of comprehensive income in the finance income or expense line. Other than derivative financial instruments which are not designated as hedging instruments, the Group does not have any assets held for trading nor does it voluntarily classify any financial assets as being at fair value through profit or loss.

Amortised cost

These assets arise principally from the provision of goods and services to customers (e.g. trade receivables), but also incorporate other types of financial assets where the objective is to hold these assets in order to collect contractual cash flows and the contractual cash flows are solely payments of principal and interest. They are initially recognised at fair value plus transaction costs that are directly attributable to their acquisition or issue and are subsequently carried at amortised cost using the effective interest rate method, less provision for impairment.

Impairment requirements use an 'expected credit loss' ('ECL') model to recognise an allowance. Impairment is measured using a 12- month ECL method unless the credit risk on a financial instrument has increased significantly since initial recognition in which case the lifetime ECL method is adopted. For receivables, a simplified approach to measuring expected credit losses using a lifetime expected loss allowance is available and has been adopted by the Group. During this process the probability of the non-payment of the trade receivables is assessed. This probability is then multiplied by the amount of the expected loss arising from default to determine the lifetime expected credit loss for the trade receivables. For trade receivables, which are reported net, such provisions are recorded in a separate provision account with the loss being recognised within administrative expenses in the consolidated statement of comprehensive income. On confirmation that the trade receivable will not be collectable, the gross carrying value of the asset is written off against the associated provision.

The Group's financial assets measured at amortised cost comprise trade and other receivables, and cash and cash equivalents in the consolidated statement of financial position.

 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short term highly liquid investments with original maturities of three months or less, and - for the purpose of the statement of cash flows - bank overdrafts. Bank overdrafts are shown within loans and borrowings in current liabilities on the consolidated statement of financial position.

Financial liabilities

The Group classifies its financial liabilities into one of two categories, depending on the purpose for which the liability was acquired. The Group's accounting policy for each category is as follows:

 

Fair value through profit or loss

 

This category comprises out-of-the-money derivatives where the time value does not offset the negative intrinsic value (see "Financial assets" for in-the-money derivatives and out-of-money derivatives where the time value offsets the negative intrinsic value). They are carried in the consolidated statement of financial position at fair value with changes in fair value recognised in the consolidated statement of comprehensive income. The Group does not hold or issue derivative instruments for speculative purposes, but for hedging purposes. Other than these derivative financial instruments, the Group does not have any liabilities held for trading nor has it designated any financial liabilities as being at fair value through profit or loss.

 

Other financial liabilities 

 

Other financial liabilities include the following items:

·

Bank loans which are initially recognised at fair value net of any transaction costs directly attributable to the issue of the instrument. Such interest-bearing liabilities are subsequently measured at amortised cost ensuring the interest element of the borrowing is expensed over the repayment period at a constant rate.

·

Trade payables, other borrowings and other short-term monetary liabilities, which are initially recognised at fair value and subsequently carried at amortised cost using the effective interest method.

 

Derivative financial instruments

The Group enters into a variety of derivative financial instruments to manage its exposure to foreign exchange rate risk, through the use of foreign exchange rate forward contracts.

 

Derivatives are initially recognised at fair value at the date the derivative contracts are entered into and are subsequently re-measured to their fair value at the end of each reporting period. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

 

Foreign currencies

Transactions entered into by Group entities in a currency other than the currency of the primary economic environment in which they operate (their "functional currency") are recorded at the rates ruling when the transactions occur. Foreign currency monetary assets and liabilities are translated at the rates ruling at the reporting date. Exchange differences arising on the retranslation of unsettled monetary assets and liabilities are recognised immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation, in which case exchange differences are recognised in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising on the retranslation of the foreign operation.

 

Leases

All leases are accounted for by recognising a right-of-use asset and a lease liability except for:

·

leases of low value assets; and

·

leases with a duration of 12 months or less.

 

Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate inherent in the lease unless (as is typically the case) this is not readily determinable, in which case the group's incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.

 

On initial recognition, the carrying value of the lease liability also includes:

·

amounts expected to be payable under any residual value guarantee;

·

the exercise price of any purchase option granted in favour of the group if it is reasonably certain to assess that option; and

·

any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.

 

Right of use assets are initially measured at the amount of the lease liability, reduced for any lease

incentives received, and increased for:

·

lease payments made at or before commencement of the lease;

·

initial direct costs incurred; and

·

the amount of any provision recognised where the group is contractually required to dismantle, remove or restore the leased asset.

 

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Right-of-use assets are amortised on a straight-line basis over the remaining term of the lease or over the remaining economic life of the asset if, rarely, this is judged to be shorter than the lease term.

When the group revises its estimate of the term of any lease (because, for example, it re-assesses the probability of a lessee extension or termination option being exercised), it adjusts the carrying amount of the lease liability to reflect the payments to make over the revised term, which are discounted at the same discount rate that applied on lease commencement. The carrying value of lease liabilities is similarly revised when the variable element of future lease payments dependent on a rate or index is revised. In both cases an equivalent adjustment is made to the carrying value of the right-of-use asset, with the revised carrying amount being amortised over the remaining (revised) lease term.

 

When the group renegotiates the contractual terms of a lease with the lessor, the accounting depends

on the nature of the modification:

·

if the renegotiation results in one or more additional assets being leased for an amount commensurate with the standalone price for the additional rights-of-use obtained, the modification is accounted for as a separate lease in accordance with the above policy ;

·

in all other cases where the renegotiated increases the scope of the lease (whether that is an extension to the lease term, or one or more additional assets being leased), the lease liability is remeasured using the discount rate applicable on the modification date, with the right-of-use asset being adjusted by the same amount ; and

·

if the renegotiation results in a decrease in the scope of the lease, both the carrying amount of the lease liability and right-of-use asset are reduced by the same proportion to reflect the partial of full termination of the lease with any difference recognised in profit or loss. The lease liability is then further adjusted to ensure its carrying amount reflects the amount of the renegotiated payments over the renegotiated term, with the modified lease payments discounted at the rate applicable on the modification date. The right-of-use asset is adjusted by the same amount.

 

For contracts that both convey a right to the group to use an identified asset and require services to be provided to the group by the lessor, the group has elected to account for the entire contract as a lease, i.e. it does allocate any amount of the contractual payments to, and account separately for, any services provided by the supplier as part of the contract.

 

Nature of leasing activities (in the capacity as lessee)

The group leases a number of properties in the jurisdictions from which it operates with a fixed periodic rent over the lease term. The group has a total of 7 property leases.

 

Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

 

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from 'profit before tax' as reported in the consolidated statement of comprehensive income and other comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible.

 

The Group's current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

 

Deferred taxation

Deferred tax assets and liabilities are recognised where the carrying amount of an asset or liability in the combined statement of financial position differs from its tax base, except for differences arising on:

·

the initial recognition of goodwill;

·

the initial recognition of an asset or liability in a transaction which is not a business combination and at the time of the transaction affects neither accounting or taxable profit; and

·

investments in subsidiaries and jointly controlled entities where the Group is able to control the timing of the reversal of the difference and it is probable that the difference will not reverse in the foreseeable future.

 

Recognition of deferred tax assets is restricted to those instances where it is probable that taxable profit will be available against which the difference can be utilised.

The amount of the asset or liability is determined using tax rates that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the deferred tax liabilities or assets are settled or recovered. Deferred tax balances are not discounted.

Deferred tax assets and liabilities are offset when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority on either:

·

the same taxable group company; or

·

different company entities which intend either to settle current tax assets and liabilities on a net basis, or to realise the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax assets and liabilities are expected to be settled or recovered.

 

Inventories

Inventories are initially recognised at cost, and subsequently at the lower of the cost and net realisable value. Cost comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.

 

Operating segments

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision maker has been identified as the management team including the Chief Executive Officers, Managing Director and the Chief Financial Officer.

The Board considers that the Group's project activity constitutes the two operating and two reporting segments presented in Note 2, as defined under IFRS 8. Management reviews the performance of the Group by reference to total results against budget.

The total profit measures are operating profit and profit for the year, both disclosed on the face of the combined income statement. No differences exist between the basis of preparation of the performance measures used by management and the figures in the Group financial information.

Earnings per share

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders of the parent by the weighted average number of ordinary shares outstanding during the year, excluding treasury shares and shares in employee benefit trusts, determined in accordance with the provisions of IAS 33 earnings per Share. Diluted earnings per share is calculated by dividing earnings attributable to ordinary shareholders of the parent by the weighted average number of ordinary shares outstanding during the year adjusted for the potentially dilutive ordinary shares.

 

Share Capital

The Group's ordinary shares are classified as equity instruments.

 

Share-based payments

Where equity settled share options are awarded to employees, the fair value of the options at the date of grant is charged to the consolidated statement of comprehensive income over the vesting period. Non-market vesting conditions are considered by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognised over the vesting period is based on the number of options that eventually vest. Non-vesting conditions and market vesting conditions are factored into the fair value of the options granted. As long as all other vesting conditions are satisfied, a charge is made irrespective of whether the market vesting conditions are satisfied. The cumulative expense is not adjusted for failure to achieve a market vesting condition or where a non-vesting condition is not satisfied.

 

Where the terms and conditions of options are modified before they vest, the increase in the fair value of the options, measured immediately before and after the modification, is also charged to the consolidated statement of comprehensive income over the remaining vesting period.

 

Where equity instruments are granted to persons other than employees, the consolidated statement of comprehensive income is charged with the fair value of goods and services received.

 

Dividends

Dividends are recognised when they become legally payable. In the case of interim dividends to equity shareholders, this is when declared by the directors. In the case of final dividends, this is when approved by the shareholders at the annual general meeting.

 

Changes in accounting policies

 

New standards, interpretations and amendments that are effective for the first time for the financial year beginning 31 December 2022

IFRS 3

Amendments updating a reference to the conceptual framework

IFRS 9

Amendments resulting from the annual improvements to IFRS Standards 2018-2020 (fees in the '10 percent' test for derecognition of financial liabilities)

IAS 16

Amendments prohibiting a Company from deducting the cost of property, plant and equipment amounts received from selling items while the Company is preparing the asset for its intended use.

IAS 37

Amendments regarding the costs to include when assessing whether contracts are onerous

 

New standards, interpretations and amendments effective from 1 January 2023

 

 

At the date of authorisation of these financial statements, certain new standards, amendments and interpretations to existing standards have been published by the IASB and adopted by the EU but are not yet effective and have not been adopted early by the Group. Management anticipates that all of the relevant pronouncements will be adopted in the Group's accounting policies for the first period beginning after the effective date of the pronouncement. Information on new standards, amendments and interpretations that are expected to be relevant to the Group's financial statements is provided below. Certain other new standards and interpretations have been issued but are not expected to have a material impact on the Group's financial statements.

 

 

Effect annual periods beginning before or after

IFRS 4

Amendments regarding the expiry date of the deferral approach

1st January 2023

IFRS 17

Insurance contracts

1st January 2023

IFRS 17

Amendments regarding comparative information for initial application of IFRS 17 and IFRS 9

1st January 2023

IAS 1

Amendments regarding disclosure of accounting policies

1st January 2023

IAS 1

Amendments regarding the classification of covenants

IAS 8

Amendments regarding the definition of accounting estimates

1st January 2023

IAS 12

Amendments resulting from deferred tax assets and liabilities arising from a simple transaction

1st January 2023

IFRS 16

Amendments to clarify seller-lessee subsequently measured sale and leaseback transactions

1st January 2024

 

Critical accounting judgements and key sources of estimation uncertainty  

The Group makes certain estimates and assumptions regarding the future. Estimates and judgements are continually evaluated based on historical experience and other factors, including the expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.

Key sources of estimation uncertainty

 

a) Inventories

Inventories are initially recognised at cost, and subsequently at the lower of the cost and net realisable value. There is judgement involved in assessing the level of inventory provision required in respect of slow-moving inventory. Inventory is carried at a value of £18.7 million at the year end.

The Group makes a 50% provision for perishable items of stock that are greater than two years old. Should the Group increase the provision to 100% of perishable items that are greater than two years old, this would decrease profit by £303,327. The Group does not provide any provision on its non-perishable goods that are greater than two years old on the basis that the products have long shelf life. Should the Group increase the provision to 100% of non-perishable items that are greater than two years old, this would decrease profit by £163,653.

b) Valuation of goodwill

The assessment of the recoverable amount of goodwill allocated to Retra Holdings Limited, Marvin Leeds Marketing Services, Inc. and Treasured Scents Limited, as detailed in note 9, was based on fair value less costs to sell and value in use calculations which involved judgements over the assumptions applied. For Retra Holdings Limited, a 1% increase in the discount rate from 13.3% to 14.3% would reduce the value in use by approximately £5.1 million leaving headroom of £44 million above the carrying value. For Marvin Leeds Marketing Services, Inc., a 1% increase in the discount rate from 10.4% to 11.4% would reduce the value in use by approximately £0.8 million leaving headroom of £4.6 million above the carrying value. For Treasured Scents Limited, a 1% increase in the discount rate from 13.3% to 14.3% would reduce the value in use by approximately £0.6 million leaving headroom of £6.2 million above the carrying value. None of these scenarios would therefore result in any impairment of the goodwill.

Critical accounting judgements

 

c) Deferred tax assets

Deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the assets to be recovered.

2. Segmental information

 

For management purposes, the Group is organised into two operating segments; Branded and Close-out. The segment 'Branded' relates to the sale of own branded products whereas 'Close-out' relates to the purchase of third-party stock which is then repackaged for sale. These segments are the basis on which the Group reports internally to the Board. The executive directors Sam Bazini, Eoin Macleod and Neil Rodol together with members from the Groups senior management teams are the chief operating decision makers of the whole business.

Year ended 31 December

2022

2022

2022

2021

2021

2021

Own Brand

Close-out

Total

Own Brand

Close-out

Total

£'000

£'000

£'000

£'000

£'000

£'000

 

Revenue

60,288

3,770

64,058

45,525

4,478

50,003

Cost of sales

(38,327)

(2,397)

(40,724)

(30,131)

(2,964)

(33,095)

Gross profit

21,961

1,373

23,334

15,394

1,514

16,908

Administrative expenses

(14,319)

(896)

(15,215)

(11,389)

(1,120)

(12,509)

Exceptional items

(143)

(9)

(152)

(586)

-

(586)

Segment result

7,499

468

7,967

3,419

394

3,813

Reconciliation of segment result to profit before tax:

Segment result

7,499

468

7,967

3,419

394

3,813

Finance expense

(277)

-

(277)

(88)

-

(88)

Profit before tax

7, 222

468

7,690

3,331

394

3,725

Analysis of total revenue by geographical market:

UK

24,277

3,287

27,564

21,358

3,965

25,323

Europe - Other

6,942

13

6,955

5,627

41

5,668

Europe - Spain

8,005

194

8,199

5,484

138

5,622

Europe - Denmark

12,822

98

12,920

6,741

8

6,749

Rest of World - USA

5,163

178

5,341

2,650

326

2,976

Rest of World - Australia and New Zealand

1,565

-

1,565

2,567

-

2,567

Rest of World - Other

1,514

-

1,514

1,098

-

1,098

 

Total

60,288

3,770

64,058

45,525

4,478

50,003

 

 

During the year ended 31 December 2022, revenues of approximately £11.2 million (2021: £5.1 million) were derived from a single external customer based in Denmark (17.5%; 2021: 10.2%).

 

The Directors are not able to attribute the Group's assets and liabilities by reportable business segment.

Analysis of non-current assets by geographical market.

Year ended 31 December

2022

2022

2022

2021

2021

2021

 

UK

USA

Total

UK

USA

Total

£'000

£'000

£'000

£'000

£'000

£'000

Goodwill

6,720

554

7,274

6,720

554

7,274

Customer lists

-

160

160

1,072

374

1,446

Brand

-

3

3

683

-

683

Patents

105

-

105

127

-

127

Website

9

-

9

4

-

4

Property, plant and equipment

1,427

5

1,432

1,379

6

1,385

Right of use assets

5,624

35

5,659

2,995

78

3,073

 

 

13,885

757

14,642

12,980

1,012

13,992

 

 

 

3. Operating profit

 

Operating profit for the period is stated after charging/(crediting):

Year ended 31 December

2022

2021

£'000

£'000

Foreign exchange gain

(133)

(614)

Depreciation

761

648

Amortisation of right-of-use assets

965

690

Amortisation of intangible assets

1,995

2,394

Movement of inventories at net realisable value

(151)

(5)

Exceptional costs

152

586

 

The expenditure incurred within the table above falls wholly within Administrative expenses.

 

Exceptional costs

 

Year ended 31 December

 

2022

2021

 

£'000

£'000

Non-recurring legal and professional fees

-

187

Royalty claim and associated legal fees

152

370

Restructuring costs

-

29

 

 

152

586

 

 

During the year the Group agreed a settlement regarding a dispute with a third party relating to the historic use of content on the Group's social media platforms in the period from 2018 through to early 2021. The total settlement including associated legal costs was £0.52 million, of which £0.37 million was provided for in the year to 31 December 2021. The payment and the restriction of content use will not affect the ongoing operations of the Group's businesses.

 

Auditor's Remuneration

 

Analysis of auditor's remuneration is as follows:

Year ended 31 December

2022

2021

£'000

£'000

 

 

Fees payable to the Company's auditor for the audit of the Group's annual accounts

91

64

Fees payable to the Company's auditor for the audit of subsidiary companies

106

101

197

165

Other services pursuant to legislation:

Tax advice

15

28

Other assurance

3

2

Total non-audit fees

18

30

 

4. Staff costs

 

 

Year ended 31 December

2022

2021

£'000

£'000

 

 

Wages and salaries

6,103

5,232

Social security costs

738

553

Pension costs (note 24)

101

88

6,942

5,873

 

The average monthly number of employees during the period was as follows:

 

Year ended 31 December

2022

2021

No.

No.

Directors

7

7

Administrative

24

27

Finance

9

8

Warehouse

58

48

Sales

13

11

New Product Development and PR

14

12

125

113

 

 

 

 2022

 2021

Directors' remuneration, included in staff costs

£'000

£'000

Salaries

985

858

Share based payments (note 21)

125

117

Benefits

23

20

Pension contributions

2

4

1,135

999

 

Remuneration in respect of Directors was as follows:

 

Salary/ fees and bonus

Share based payment

Benefits

Pension contribution

2022

Total Remuneration

2021

£'000

£'000

£'000

£'000

£'000

£'000

Executive Directors

S Bazini

260

27

13

-

300

281

E Macleod

260

27

10

-

297

279

N Rodol

212

50

-

1

263

223

S Craig

63

1

-

1

65

63

P Hagon*

40

20

-

-

60

40

Non-executive Directors

C Garston

66

-

-

-

66

60

K Sadler

44

-

-

-

44

40

J Collier**

40

-

-

-

40

13

985

125

23

2

1,135

999

 

* Shares granted to consultancy company Ward & Hagon Management Consulting LLP, of which director Paul Hagon is a member.

** Appointed 1 September 2021 and resigned 31 December 2022.

Directors' interests in share options for year ended 31 December 2022

As at 31 December 2022, the following Directors held the following performance related share awards (Enterprise Management Incentive Scheme Options, LTIPs or CSOPs) over ordinary shares of 25p each under the Warpaint London plc Enterprise Management Incentive Scheme, the Long Term Incentive Plan and the Warpaint London plc Company Share Option Plan. For details of the share option schemes see Note 21 in the Financial Statements.

Type of Share Award

Date of Grant

Number of Shares at 31 December 2022

Exercise Price

End of Performance Period/First Exercise Date

Number of Shares at 31 December 2021 (or date of appointment if later)

S Bazini

LTIP

21.09.2018

1,534,986

254.5p

31.12.2022

1,534,986

E Macleod

LTIP

21.09.2018

1,534,986

254.5p

31.12.2022

1,534,986

N Rodol

EMI

29.06.2017

105,262

237.5p

29.06.2020

105,262

LTIP

21.09.2018

306,996

254.5p

31.12.2022

306,996

EMI (Non-Qualifying)

24.05.2021

225,410

122.0p

24.05.2024

225,410

CSOP

24.05.2021

24,590

122.0p

24.05.2024

24,590

S Craig

EMI

29.06.2017

10,000

237.5p

29.06.2020

10,000

CSOP

20.05.2020

10,000

49.5P

20.05.2023

10,000

P Hagon

EMI (Non-Qualifying)

01.03.2022

200,000*

127.5p

01.03.2025

-

C Garston

-

-

-

-

-

-

K Sadler

-

-

-

-

-

-

J Collier**

-

-

-

-

-

-

 

* Shares granted to consultancy company Ward & Hagon Management Consulting LLP, of which director Paul Hagon is a member.

** Appointed 1 September 2021 and resigned 31 December 2022.

The Directors of the Group are the only key management personnel.

5. Net finance cost

 

Year ended 31 December

2022

2021

£'000

£'000

Interest received

4

2

Interest paid

Loan interest

-

(5)

Lease liability interest (note 16)

(185)

(84)

Other interest

(96)

(1)

(277)

(88)

 

6. Income tax

 

Year ended 31 December

2022

2021

£'000

£'000

Current tax expense

Current tax on profits for the period

1,746

1,262

1,746

1,262

Deferred tax expense

Origination and reversal of temporary differences

(377)

(367)

 

Total tax expense

1,440

895

 

 

The reasons for the difference between the actual tax charge for the year and the standard rate of corporation tax in the United Kingdom applied to profit for the year as follows:

 

Year ended 31 December

2022

2021

£'000

£'000

Profit for the period before taxation

7,690

3,725

Expected tax charge based on corporation tax rate of 19% (2021: 19%)

1,461

708

(Income)/expenses not (allowable)/deductible for tax purposes

(11)

74

Other adjustments

(41)

1

Different tax rates applied in overseas jurisdiction

31

30

Adjustment to deferred tax to average rate

-

82

Total tax expense

1,440

895

The UK corporation tax at the standard rate for the year is 19.0% (2021: 19.0%).

The Group's effective tax rate for the year is 18.73% (2021 24.03%).

 

7. Subsidiaries

 

At the period end, the Group has the following subsidiaries:

Subsidiary name

Nature of business

Place of incorporation

Percentage owned

Warpaint Cosmetics Group Limited

Holding company

England and Wales

100%

Warpaint Cosmetics (2014) Limited*

Wholesaler

England and Wales

100%

Treasured Scents (2014) Limited

Holding company

England and Wales

100%

Treasured Scents Limited*

Dormant

England and Wales

100%

Warpaint Cosmetics Inc.

Holding company

U.S.A.

100%

Retra Holdings Limited

Holding company

England and Wales

100%

Badgequo Limited*

Wholesaler

England and Wales

100%

Retra Own Label Limited*

Dormant

England and Wales

100%

Badgequo Hong Kong Limited*

Supply chain management

Hong Kong

100%

Jinhua Badgequo Cosmetics Trading Co., Ltd*

Wholesaler

People's Republic of China

100%

Marvin Leeds Marketing Services, Inc.*

Wholesaler

U.S.A.

100%

Warpaint Cosmetics (ROI) Limited

Wholesaler

Republic of Ireland

100%

* indicates indirect interest

 

All entities detailed above have been in existence for the whole of the reporting period.

 

The registered office for all UK incorporated subsidiaries is Units B&C, Orbital Forty-Six, The Ridgeway Trading Estate, Iver, Bucks. SL0 9HW.

 

The registered office for Warpaint Cosmetics Inc.is 445 Northern Boulevard - Great Neck, New York 11021.

 

 

The registered office for Badgequo Hong Kong Limited is 12F, 3 Lockhart Road, Wanchai, Hong Kong.

 

The registered office for Jinhua Badgequo Cosmetics Trading Co. Ltd is Room 1401, Gongyuan Building No. 307 South Shuanglong Street, Wucheng District, Jinhua, Zhejiang, China 321000.

 

The registered office for Marvin Leeds Marketing Services, Inc. is 34W. 33rd St. - Suite 301, New York NY 10001.

The registered office for Warpaint Cosmetics (ROI) Limited is 6th Floor, South Bank House, Barrow Street, Dublin 4, D04 TR29.

8. Goodwill

Cost

£'000

At 1 January 2021

8,086

At 31 December 2021

8,086

At 1 January 2022

8,086

At 31 December 2022

8,086

Impairment

At 1 January 2021

812

 

Impairment during the year

-

At 31 December 2021

812

At 1 January 2022

812

At 31 December 2022

812

Net book value

At 31 December 2022

7,274

At 31 December 2021

7,274

 

Goodwill represents the excess of consideration over the fair value of the Group's share of the net identifiable assets of the acquired business/CGU at the date of acquisition. The carrying value at 31 December 2022 includes Treasured Scents (2014) Limited ("TS2014") (the Close-out business) of £513,000, Retra Holdings Limited £6,207,000 and Marvin Leeds Marketing Services, Inc. £554,000.

Impairment is calculated by comparing the carrying amounts to the recoverable amount being the higher of value in use derived from discounted cash flow projections or the fair value less costs to sell. A CGU is deemed to be an individual division, and these have been grouped together into similar classes for the purpose of formulating operating segments as reported in Note 2. Value in use calculations are based on a discounted cash flow model ("DCF") for the subsidiary, which discounts expected cash flows over a five-year period using a post-tax discount rate of 13.3% (2021: 10.0%) for Retra Holdings Limited and 10.4% (2021: 11.4%) for Marvin Leeds Marketing Services, Inc. and 13.3% for TS2014 (2021: 10%). Cash flows beyond the five-year period are extrapolated using a long-term average growth rate of 2.0% (2021: 2.0%). The average growth rate beyond the five-year period is lower than current growth rates and is in line with Management's expectations for the business.

The fair value less costs to sell was based on a multiple of earnings less estimated costs to sell. Management have performed the annual impairment review as required by IAS 36 and have concluded that no impairment is indicated for TS2014, Retra Holdings Limited ("Retra") or Marvin Leeds Marketing Services, Inc. ("LMS") as the recoverable amounts exceeds the respective carrying values.

Key assumptions and sensitivity to changes in assumptions

The key assumptions are based upon management's historical experience. The calculation of VIU is most sensitive to the following assumptions:

·

Sales and gross margin - for LMS this is based on forecasts incorporating a compound annual growth rate of 15% revenue over the next five years. For Retra, the compound annual growth rate over the next five years is anticipated to be 15%. For Treasured Scents the compound annual growth rate over the next five years is anticipated to be 2.5% in the year ended 31 December 2022. The gross margins for LMS, Retra and Treasured Scents are based on historical rates achieved.

·

Administrative expenses are expected to increase by 5% in LMS, 15% in Retra and 5% in Treasured Scents in the year ending 31 December 2023 with 5% incremental increases annually thereafter.

·

Discount Rate - pre-tax discount rate of 13.3% for Retra Holdings Limited, 10.4% for Marvin Leeds Marketing Services, Inc. and 13.3% for Treasured Scents reflects the Directors' estimate of an appropriate rate of return, considering the relevant risk factors.

·

Growth Rate - used to extrapolate beyond the budget period and for terminal values based on a long-term average growth rate of 2.0%.

 

Sensitivity to changes in assumptions

The impairment review of the Group is sensitive to changes in the key assumptions, most notably the pre-tax discount rate, the terminal growth rate, the projected operating cash flows. Reasonable changes to these assumptions are considered to be:

·

1.0% increase in the pre-tax discount rate;

·

reduction in the terminal growth rate to 1%; and

·

10.0% reduction in projected operating cash flows.

Reasonable changes to the assumptions used, considered in isolation, would not result in an impairment of goodwill for LMS, Retra or TS2014.

9. Intangible assets

Brands

Customer lists

Patents

Website

Licences

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

Cost

At 1 January 2021

3,802

8,240

264

45

6

12,357

Additions

-

-

3

-

-

3

At 31 December 2021

3,802

8,240

267

45

6

12,360

Additions

-

1

3

8

-

12

 

At 31 December 2022

3,802

8,241

270

53

6

12,372

Accumulated amortisation

At 1 January 2021

2,350

5,198

116

37

5

7,706

Charge for the year

765

1,600

24

4

1

2,394

At 31 December 2021

3,115

6,798

140

41

6

10,100

Charge for the year

684

1,283

25

3

-

1,995

At 31 December 2022

3,799

8,081

165

44

6

12,095

Net book value

At 31 December 2022

3

160

105

9

-

277

At 31 December 2021

687

1,442

127

4

-

2,260

 

10.  Property, plant and equipment

 

Plant and machinery

Fixtures and fittings

Computer equipment

Motor vehicles

Total

£'000

£'000

£'000

£'000

£'000

Costs

At 1 January 2021

252

1,673

344

120

2,389

 

Reclassification to right-of-use assets

Additions

15

558

23

-

596

Transfer from right-of-use assets

760

-

-

-

760

At 31 December 2021

1,027

2,231

367

120

3,745

Additions

301

409

91

30

831

Disposals

-

(349)

(3)

(72)

(424)

Foreign exchange gain/loss

(37)

-

16

-

(21)

At 31 December 2022

1,291

2,291

471

78

4,131

 

Accumulated depreciation

At 1 January 2021

100

785

251

104

1,240

 

Charge for year

189

410

39

11

649

Transfer from right-of-use assets

471

-

-

-

471

 

At 31 December 2021

760

1,195

290

115

2,360

Charge for year

181

538

37

5

761

Disposals

-

(349)

(1)

(72)

(422)

At 31 December 2022

941

1,384

326

48

2,699

Net book value

At 31 December 2022

350

907

145

30

1,432

At 31 December 2021

267

1,036

77

5

1,385

 

Transferred from right of use assets category represents the return of ROU assets at expiry of the lease and where title is transferred to the Group.

 

 

11. Right-of-use assets

 

Leasehold property

Plant and machinery

Computer equipment

Total

£'000

£'000

£'000

£'000

Costs

At 1 January 2021

4,796

760

77

5,633

 

Additions

253

-

-

253

Transfer to property, plant and equipment

-

(760)

-

(760)

At 31 December 2021

5,049

-

77

5,126

 

Additions

3,551

-

-

3,551

Transfer to property, plant and equipment

-

-

-

-

At 31 December 2022

8,600

-

77

8,677

 

 

Accumulated amortisation

At 1 January 2021

1,286

471

77

1,834

 

Charge for the year

690

-

-

690

Transfer to property, plant and equipment

-

(471)

-

(471)

 

At 31 December 2021

1,976

-

77

2,053

 

 

 

 

 

Charge for the year

965

-

-

965

Transfer to property, plant and equipment

-

-

-

-

 

At 31 December 2022

2,941

-

77

3,018

Net Book Value

 

 

 

 

 

 

 

 

At 31 December 2022

5,659

-

-

5,659

At 31 December 2021

3,073

-

,-

3,073

 

Transferred from right of use assets category represents the return of ROU assets at expiry of the lease and where title is transferred to the Group.

 

The weighted average incremental borrowing rate applied to measure lease liabilities is 3.99% (2021: 3.73%) for leasehold property.

 

 

12. Inventories

 

 

As at 31 December

2022

2021

£'000

£'000

Finished goods

19,080

18,655

Provision for impairment

(365)

(516)

18,715

18,139

The cost of inventories recognised as an expense and included in 'cost of sales' amounted to £35.09 million in the year ended 31 December 2022 (2021: £28.56 million).

 

13. Trade and other receivables

 

As at 31 December

2022

2021

 

£'000

£'000

Trade receivables - gross

9,935

8,755

Provision for impairment of trade receivables

(70)

(66)

Trade receivables - net

9,865

8,689

Other receivables

213

92

Prepayments and accrued income

1,615

1,541

Total

11,693

10,322

 

The directors consider that the carrying values of trade and other receivables measured at book value and amortised cost approximates to their fair value.

 

The individually impaired receivables relate to the supply of goods to customers. A provision is recognised for amounts not expected to be recovered. Movements in the accumulated impairment losses on trade receivables were as follows:

 

 

As at 31 December

2022

2021

£'000

£'000

Accumulated impairment losses at 1 January

66

44

Additional impairment losses recognised during the year, net

4

66

Amounts written off during the year as uncollectible

-

(44)

Accumulated impairment losses at 31 December

70

66

 

The impairment losses recognised during the year are net of a credit of £9,000 (2021: Nil) relating to the recovery of amounts previously written off as uncollectable.

 

Contract Liabilities

 

 

As at 31 December

2022

2021

£'000

£'000

At 1 January

219

292

Amounts included in contract liabilities that was recognised as revenue during the period

525

530

Amounts settled during the period

(501)

(603)

At 31 December

243

219

 

Contract liabilities are included within "trade and other receivables" in the face of the statement of financial position being settled net of the trade debtor balances. They arise from the group's own brand segment, which enter into contracts with customers for early settlement discounts, marketing contributions and volume rebates, because the invoiced amounts to customers at each balance sheet date do not consider the amount or rebate and discounts the customers are entitled to until settlement of the debtor balance at a certain time.

 

14. Cash and cash equivalents

 

Cash and cash equivalents include the following for the purposes of the cash flow statement:

 

 

As at 31 December

2022

2021

£'000

£'000

Cash at bank and in hand

5,865

4,072

5,865

4,072

 

15. Trade and other payables

 

 

As at 31 December

2022

2021

£'000

£'000

Current

Trade payables

1,368

1,847

Social security and other taxes

1,294

293

Other payables

101

66

Accruals and deferred income

3,225

4,087

Total

5,988

6,293

 

 

The directors consider that the carrying values of trade and other payables measured at book value and amortised cost approximates to their fair value.

 

16.  Loans and borrowings

 

 

As at 31 December

2022

2021

£'000

£'000

Bank loans

Repayable within 1 year

-

-

Repayable within 2 - 5 years

-

-

-

-

Lease liabilities

Repayable within 1 year

1,015

610

Repayable within 2 - 5 years

3,498

2,261

Repayable in more than 5 years

1,349

276

5,862

3,147

Total

Repayable within 1 year

1,015

610

Repayable within 2 - 5 years

3,498

2,261

Repayable in more than 5 years

1,349

276

5,862

3,147

 

 

Undiscounted lease payments

 

 

As at 31 December

2022

2021

£'000

£'000

Lease liabilities

Repayable within 1 year

1,200

684

Repayable within 2 - 5 years

4,027

2,390

Repayable in more than 5 years

1,465

281

Total

6,692

3,355

 

 

 

Lease liabilities

 

As at 31 December

Leasehold property

Plant and machinery

Computer equipment

Total

£'000

£'000

£'000

£'000

 

 

 

 

At 1 January 2021

3,659

252

-

3,911

Lease additions

253

-

-

253

Interest expense

84

-

-

84

Lease payments

(765)

(252)

-

(1,017)

Prior period adjustment

(84)

-

-

(84)

 

 

 

 

 

As at 31 December 2021

3,147

-

-

3,147

Lease additions

3,551

-

-

3,551

Interest expense

185

-

-

185

Lease payments

(1,021)

-

-

(1,021)

As at 31 December 2022

5,862

-

-

5,862

 

 

Nature of lease liabilities

The group leases a number of properties in the United Kingdom and United States of America.

 

An additional £Nil (2021: £1,061) has been expensed to the statement of comprehensive income in respect of low value operating leases. Interest payments of £Nil (2021: £Nil) have also been expensed in respect of leases that expired during the period.

 

The interest rates expected are as follows:

As at 31 December

 

2022

2021

 

%

%

Finance loans

-

7.0

Bank loans

-

8.75

Invoice financing

5.49¹

3.25

Note 1: Base rate + 1.99%

 

Secured loans

The borrowings of the subsidiary companies, Retra Holdings Limited and Badgequo Limited, are secured by a debenture including a fixed charge over the present leasehold property, a first fixed charge over book and other debts and a first floating charge over all assets of those companies.

 

Bank borrowings include stock and invoice financing facilities amounting to £Nil (2021: £Nil). The carrying value of assets pledged as collateral approximates to £10,259,284 (2021: £8,205,000).

 

17.  Deferred tax

 

Deferred tax is calculated in full on temporary differences under the liability method using tax rate of 19% - 25%.

The movement on the deferred tax account is as shown below:

 

 

Deferred tax liability

Deferred tax asset

 

Year ended 31 December

Year ended 31 December

2022

2021

2022

2021

£'000

£'000

£'000

£'000

Opening balance

(557)

(1,000)

500

581

Foreign exchange adjustment

-

-

(71)

-

Recognised in profit and loss:

Tax expense

377

443

-

(81)

Closing balance

(180)

(557)

429

500

 

The deferred tax liability has arisen due to the timing difference on accelerated capital allowances amounting to £65,000 (2021: £65,000) and on the intangible assets acquired in a business combination amounting to £115,000 (2021: £492,000).

 

Deferred tax asset has arisen from loss carry forward for LMS amounting to £1,716,000 (2021: £1,995,000) and recognised at a rate of 25%.

 

18.  Dividends

 

Year to December 2022

Paid

Amount per share

Total £'000

 

 

 

Final dividend - 2021

05 July 22

3.5p

2,686

Interim dividend - 2022

25 Nov 22

2.6p

1,996

4,682

Year to December 2021

Paid

Amount per share

Total £'000

 

 

 

Final dividend - 2020

05 July 21

3.0p

2,303

Interim dividend - 2021

11 Nov 21

2.5p

1,919

4,222

 

The group has proposed a final dividend for the year ended 31 December 2022 of 4.5p per share.

 

19.  Called up share capital

 

No. of shares

 

'000

£'000

Allotted and issued

Ordinary shares of £0.25 each:

At 1 January 2021

76,749

19,187

Issued at 12 May 2021

3

1

At 31 December 2021

76,752

19,188

At 31 December 2022

76,752

19,188

 

All ordinary shares carry equal rights.

 

20.  Reserves

 

Share premium

The share premium reserve contains the premium arising on the issue of equity shares, net of issue expenses incurred by the Company.

 

Retained earnings

Retained earnings represent cumulative profits or losses, net of dividends and other adjustments.

 

Merger reserve

The merger reserve arose due to the group reconstruction in 2016. The effect of the application of merger accounting principles on the merger reserve is that the share capital and other distributable reserves that existed in Warpaint Cosmetics Group Limited (the Company) as at the point Warpaint London PLC legally acquired Warpaint Cosmetics Group Limited is accounted for as if it had been in existence as at 31 December 2015 and as at 1 January 2015. The corresponding entry being the merger reserve so the overall net assets as at the comparative dates are not affected.

 

Share option reserves

'Share option reserves' have arisen from the share-based payment charge. The shares over which the options were issued are that of the parent company. 'Other reserves' have also arisen on translation of foreign subsidiaries.

 

21.  Share based payments

 

Movements in the number of options and their weighted average exercise prices are as follows:

 

 

 

Weighted average exercise price (pence)

Number of options

Weighted average exercise price (pence)

Number of options

2022

2022

2021

2021

Outstanding at the beginning of the year

226.00

4,860,830

233.50

4,528,962

Granted during the year

127.95

220,000

122.00

400,000

Expired during the year

55.40

(26,842)

115.00

(68,132)

Other adjustments

80.09

15,526

Outstanding at the end of the year

222.20

5,069,514

226.00

4,860,830

 

The weighted average remaining contractual life of the options is 1.34 years (2021: 2.64 years).

 

The following options over ordinary shares have been granted by the Company:

Exercise price

Exercise period

Number of options

Pence

(years)

 

29 June 2017

237.50

3

255,051

24 September 2018

254.50

5

3,837,462

20 May 2020

49.50

3

454,686

25 May 2021

122.0

3

400,000

01 March 2022

127.50

3

200,000

17 October 2022

132.50

3

20,000

 

At the date of grant, the options were valued using the Black-Scholes option pricing model. The fair value per options granted and the assumptions used in the calculations were as follows:

 

17 Oct 22

01 Mar 22

25 May 21

20 May 20

24 Sept 18

29 June 17

Expected volatility

48%

54%

78%

76%

78%

64%

Expected life (years)

3

3

3

3

2-4

3

Risk-free interest rate

2.77%

0.99%

0.15%

0.01%

1.61%

0.38%

Expected dividend yield

3.24%

4.94%

1.76%

2.08%

1.53%

2%

Fair value per option (£)

0.383

0.354

0.552

0.213

0.422

0.963

 

On 29 June 2017, the Company granted in aggregate over 277,788 ordinary shares of 25 pence each in the Company under the Enterprise Management Incentive Scheme to all staff members, including the Company's Chief Financial Officer, Neil Rodol, but excluding all other directors. The Options are exercisable for a period of seven years from 29 June 2020 (three years after the grant date), subject to certain performance conditions being met, including that the compound annual growth rate in the Company's earnings per share must exceed 8 per cent over the three financial years commencing 1 January 2017, subject to the discretion of the Company's remuneration committee.

 

On 24 September 2018, share options with an exercise price of 254.50p, equal to the closing mid-market value immediately prior to the date of grant, and subject to the achievement of demanding Earnings Per Share ("EPS") and Total Shareholder Return ("TSR") performance conditions measured over a period of up to 5 years were granted to certain directors.

 

The share options are exercisable up to 10 years from the date of grant. Vesting is subject to the performance conditions set out below: 

·

50% of the award is subject to an adjusted EPS growth performance condition. One third of this portion of the award will be tested and vest after three, four and five years. Vesting is based on adjusted EPS in the years ending Dec 2020, 2021 and 2022. Threshold vesting of 20% of the award is achieved at 12.5% compound annual EPS growth and full vesting at 22.5% compound annual EPS growth, measured from 31 December 2017.

·

50% of the award is subject to an absolute TSR performance condition tested following the announcement of results for the years ending 31 December 2020, 2021 and 2022. Threshold vesting of 20% of the award is achieved at 8% compound annual TSR and straight line vesting up to 100% vesting at 18% compound annual TSR, measured from 31 December 2017.

 

An additional grant of 460,494 share options with the same terms was made on the same date to three senior management individuals of the Company.

 

On 20 May 2020, the Company granted, in aggregate, 454,686 share options with an exercise price of 49.50 pence per Ordinary share under a Company Share Option Plan (CSOP). Key persons discharging managerial responsibilities (PDMR's) were awarded a cumulative 112,106 share options as part of their annual remuneration and incentivisation packages. The remaining 342,580 options granted have been awarded to other members of the company's workforce. No directors of the company were awarded options in relation to this CSOP. The options are exercisable for a period of seven years from 20 May 2023, subject to the same performance conditions dictated by the Enterprise Management Incentive Scheme detailed above.

 

On 25 May 2021, the Company granted, in aggregate, 400,000 share options with an exercise price of 122.0 pence per Ordinary share under a Company Share Option Plan (CSOP). Key persons discharging managerial responsibilities (PDMR's) were awarded a cumulative 400,000 share options as part of their annual remuneration and incentivisation packages. The options are exercisable for a period of seven years from 24 May 2024 and are not subject to the satisfaction of any performance criteria.

 

On 1 March 2022, the Company granted in aggregate 200,000 ordinary shares of 25 pence each at an exercise price of 127.5 pence each under an unapproved scheme. These were granted to a consultancy company Ward & Hagon Management Consulting LLP ("Ward & Hagon") appointed to assist with the implementation of the Company's strategic growth plan in recognition of the success of the arrangements at the time and to incentivise the consultancy company to align with the long-term interest of shareholders. The options are exercisable between three and ten years from the date of grant.

 

On 17 October 2022, the Company granted in aggregate 20,000 ordinary shares of 132.5 pence each under a Company Share Option Plan (CSOP) scheme. The options are exercisable between three and ten years from the date of grant, with the usual first exercise date being the 3rd anniversary of the date of the grant.

 

The charge in the statement of comprehensive income for the share-based payments during the year was £192,986 (2021: £177,000).

 

22. Related party transactions

 

Transactions between the Company and its subsidiaries, which are related parties, have been eliminated on consolidation.

 

Key management personnel are considered to be the directors. Compensation of the directors is disclosed in note 4 with the exception of dividends which are disclosed in note 18.

 

During 2022, Warpaint Cosmetics (2014) Limited paid rent in the sum of £138,000 (2021: £120,000) to Direct Supplies (2014) Group Limited, of which S Bazini is a director. At the year end the amount due to Direct Supplies (2014) Group Limited was £34,500 (2021: £30,000).

 

During 2022, Warpaint Cosmetics (2014) Limited paid rent in the sum of £138,000 (2021: £120,000) to Trading Scents Group Limited, of which E Macleod is a director. At the year end the amount due to Trading Scents Group Limited was £34,500 (2021: £30,000).

 

During 2022, Warpaint Cosmetics (2014) Limited paid rent in the sum of £138,000 (2021: £120,000) to Warpaint Cosmetics limited, of which S Bazini and E Macleod are directors. At the year end the amount due to Warpaint Cosmetics Limited was £34,500 (2021: £30,000).

 

During 2022, Retra Holdings Limited paid rent in the sum of £404,265 (2021: £340,000) to Warpaint Cosmetics Limited, of which E Macleod and S Bazini are directors.

 

Paul Hagon, an executive director of Warpaint London plc ("Warpaint"), is a member of Ward & Hagon. Ward & Hagon were paid £177,437 fees (2021: £200,0000), £169,172 commission (2021: £20,010) and expenses of £7,404 in 2022 (2021: £7,941) and were issued with 200,000 share options, details of which are disclosed in note 21.

 

23.  Financial instruments

 

Capital risk management

The Board has overall responsibility for the determination of the Group's risk management objectives and policies. The overall objective of the Board is to set policies that seek to reduce risk as far as possible without unduly affecting the Group's competitiveness and flexibility. The Group reports in Sterling. All funding requirements and financial risks are managed based on policies and procedures adopted by the Board of Directors.

The Group manages its capital to ensure its ability to continue as a going concern and to maintain an optimal capital structure to reduce cost of capital. The capital structure of the Group comprises equity attributable to equity holders of the Company consisting of invested capital as disclosed in the Statement of Changes in Equity and cash and cash equivalents.

The Group's invested capital is made up of share capital, share premium and retained earnings totalling £51,926,000 as at 31 December 2022 (2021: £50,358,000) as shown in the statement of changes in equity.

The Group maintains or adjusts its capital structure through the payment of dividends to shareholders and issue of new shares.

 

 

Year ended 31 December

2022

2021

£'000

£'000

Financial assets

Financial assets at amortised cost:

Trade and other receivables

10,078

8,781

Financial assets measured at fair value through the profit and loss:

Cash and cash equivalents

5,865

4,072

Derivative financial instruments

8

545

15,951

13,398

Financial liabilities 

 

 

Financial liabilities at amortised cost:

Trade and other payables

(1,469)

(1,913)

Loan and borrowings

(5,862)

(3,147)

Financial liabilities measured at fair value through the profit and loss:

Derivative financial instruments

(600)

-

(7,931)

(5,060)

Net

8,020

8,338

 

 

Financial assets measured at fair value through the profit and loss comprise cash and cash equivalents and derivative financial instruments.

 

Financial assets measured at amortised cost comprise trade receivables and other receivables.

 

Financial liabilities measured at amortised cost comprise trade payables and other payables, and bank loans.

 

Cash and cash equivalents

This comprises cash and short-term deposits held by the Group. The carrying amount of these assets approximates their fair value.

 

General risk management principles

The Group's activities expose it to a variety of risks including market risk (interest rate risk), credit risk and liquidity risk. The Group manages these risks through an effective risk management programme and through this programme, the Board seeks to minimise potential adverse effects on the Group's financial performance. The Directors have an overall responsibility for the establishment of the Group's risk management framework. A formal risk assessment and management framework for assessing, monitoring and managing the strategic, operational and financial risks of the Group is in place to ensure appropriate risk management of its operations.

 

The following represent the key financial risks that the Group faces:

 

Market risk

The Group's activities expose it to the financial risk of interest rates.

 

Interest rate risk

The Group's interest rate exposure arises mainly from its interest-bearing borrowings. Contractual agreements entered into a floating rate expose the entity to cash flow risk. Interest rate risk also arises on

the Group's cash and cash equivalents. The Group does not enter into derivative transactions in order to hedge against its exposure to interest rate fluctuations. An increase in the rate of interest by 100 basis points would decrease profits by £12,000 (2021: £18,000) with an increase in profits by the same amount for a decrease in the rate of interest by 100 basis points.

 

Credit risk

Credit risk is the risk of financial loss to the Group if a customer or a counterparty to a financial instrument fails to meet its contractual obligations.

 

The Group's principal financial assets are trade and other receivables and bank balances and cash. The credit risk on liquid funds is limited because the counterparties are banks with high credit-ratings assigned by international credit-rating agencies.

 

The Group's credit risk is primarily attributable to trade receivables. The Group has a policy of assessing credit worthiness of potential and existing customers before entering into transactions. There is ongoing credit evaluation on the financial condition of accounts receivable using independent ratings where available or by assessment of the customer's credit quality based on its financial position, past experience and other factors. The Group manages the collection of its receivables through its ongoing contact with customers so as to ensure that any potential issues that could result in non-payment of the amounts due are addressed as soon as identified. The Group makes a provision in the financial statements for expected credit losses based on an evaluation of historical data and applies percentages based on the ageing of trade receivables.

 

The maximum exposure to credit risk in respect of the above is the carrying value of financial assets recorded in the financial statements. At 31 December 2022, the Group has trade receivables of £9,865,000 (2021: £8,689,000).

The following table provides an analysis of trade receivables that were due, but not impaired, at each financial year end. The Group believes that the balances are ultimately recoverable based on a review of past impairment history and the current financial status of customers.

 

 

As at 31 December

2022

2021

£'000

£'000

 

 

Current

5,502

4,811

1 - 30 days

2,680

2,006

31 - 60 days

1,164

1,516

61 - 90 days

375

183

91 + days

214

239

Provision for impairment of trade receivables

(70)

(66)

Total trade receivables - net

9,865

8,689

 

The Directors are unaware of any factors affecting the recoverability of outstanding balances at 31 December 2022 and, consequently, no further provisions have been made for bad and doubtful debts.

 

The allowance for bad debts has been calculated using a 12-month lifetime expected credit loss model, as set out below, in accordance with IFRS 9.

 

 

As at 31 December

As at 31 December

2022

2021

£'000

%

£'000

£'000

%

£'000

Current

5,432

0.135

8

4,811

0.135

6

1 - 30 days

2,680

0.405

11

2,006

0.405

8

31 - 60 days

1,164

1.215

14

1,516

1.215

18

61 - 90 days

375

3.645

14

183

3.645

8

91 + days

214

10.935

23

239

10.935

26

70

 

 

66

 

 

Credit quality of financial assets

 

As at 31 December

2022

2021

Trade receivables, gross (note 13):

£'000

£'000

 

 

Receivable from large companies (see below for definition)

5,115

2,600

Receivable from small or medium-sized companies

386

2,211

Total neither past due nor impaired

5,501

4,811

 

For the purpose of the Group's monitoring of credit quality, large companies or groups are those that, based on information available to management at the point of initially contracting with the entity, have annual turnover in excess of £100,000 (2021: £100,000).

 

 

As at 31 December

 

2022

2021

Past due but not impaired:

£'000

£'000

Less than 30 days overdue

2,680

2,006

30 - 90 days overdue

1,684

1,872

Total past due but not impaired

4,364

3,878

 

Lifetime expected loss provision:

Less than 30 days overdue

-

-

30 - 90 days overdue

70

66

Total lifetime expected loss provision (gross)

70

66

Less: Impairment provision

(70)

(66)

Total trade receivables, net of provision for impairment

9,865

8,689

 

Cash and cash equivalents, neither past due nor impaired (Moody's ratings of respective counterparties):

 

As at 31 December

2022

2021

 

£'000

£'000

 

 

AAA rated

-

6

AA rated

-

1,723

A rated

5,862

-

BAA rated

3

2,343

Total cash and cash equivalents

5,865

4,072

 

Liquidity risk

Liquidity risk arises from the Group's management of working capital. It is the risk that the Group will encounter difficulty in meeting its financial obligations as they fall due. The Group's policy is to ensure that it will always have sufficient cash to allow it to meet its liabilities when they become due. To achieve this aim, it closely monitors its access to bank and other credit facilities in comparison to its outstanding commitments on a regular basis to ensure that it has sufficient funds to meet the obligations as they fall due.

The Board receives monthly cash balance updates and weekly sales and margin reports marked against budget. At the start of each year the Board approve and adopt a budget and cash flow for the next 24 months, the CFO monitors these and reports any material divergences to the Board, so that management can ensure that sufficient funding is in place as it is required. The budget and cash flow are updated at the end of each year, for the following 24 months.

 

The tables below summarise the maturity profile of the combined group's non-derivative financial liabilities at each financial year end based on contractual undiscounted payments, including estimated interest payments where applicable:

 

Year ended 31 December 2022

Less than 6 months

Between 6 months and 1 year

Between 1 and 5 years

Over 5 years

Total

£'000

£'000

£'000

£'000

£'000

Trade payables

1,368

-

-

-

1,368

Other payables

1,395

-

-

-

1,395

Accruals

3,225

-

-

-

3,225

Loans and borrowings

508

507

3,498

1,349

5,862

6,496

507

3,498

1,349

11,850

 

 

Year ended 31 December 2021

Less than 6 months

Between 6 months and 1 year

Between 1 and 5 years

Over 5 years

Total

£'000

£'000

£'000

£'000

£'000

Trade payables

1,079

-

-

-

1,079

Other payables

1,137

-

-

-

1,137

Accruals

4,077

-

-

-

4,077

Loans and borrowings

302

308

2,261

276

3,147

6,595

308

2,261

276

9,440

 

The borrowings of the subsidiary companies, Retra Holdings Limited and Badgequo Limited, are secured by a debenture including a fixed charge over the present leasehold property, a first fixed charge over book and other debts and a first floating charge over all assets of those companies.

 

Foreign exchange risk

The Group operates in a number of markets across the world and is exposed to foreign exchange risk arising from various currency exposure in respect of cash and cash equivalents, trade receivables and trade payables, in particular with respect to the US dollar. At December 2022, there were total sums of £1,828,145 (2021: £939,000) held in foreign currency.

 

The Group is also exposed to currency risk as the assets one of its subsidiary are denominated in US Dollars. At 31 December 2022, the net foreign liability was £0.6m (2021: £0.7m). Differences that arise from the translation of these assets from US dollar to sterling are recognised in other comprehensive income in the year and the cumulative effect as a separate component in equity. The Group does not hedge this translation exposure to its equity.

 

A 5% weakening of sterling would result in a £18,222 increase in reported profits and equity, while a 5% strengthening of sterling would result in £16,487 decrease in profits and equity.

Marvin Leeds Marketing Services, Inc.

 

 

As at 31 December

 

2022

2022

 

 

USD

GBP

 

 

$'000

£'000

 

 

 

Profit After Tax

416,845

346,217

5% weakening of US dollar

416,845

364,439

Increase profits

18,222

5% strengthening of US dollar

416,845

329,730

Decrease profits

(16,487)

 

Foreign exchange risk

2022

2021

£'000

£'000

Derivatives carried at fair value:

Exchange (loss)/gain on forward foreign currency contracts

(592)

545

 

The Group, along with other businesses, will face the risk of inflationary pressures through commodities cost increases.

 

Derivatives: Foreign currency forward contracts

The Group enters into forward foreign exchange contracts and options to manage the risk associated with anticipated sale and purchase transactions which are denominated in foreign currencies.

 

Derivatives are recognised initially at their fair value at the date the derivative contract is entered into and are subsequently remeasured to their fair value at each reporting date. The resulting gain or loss is recognised immediately in the profit or loss unless the derivative is designed and effective as a hedging instrument, in which event the timing and recognition in the profit or loss depends on the nature of the hedging relationship.

 

As at 31 December 2022, the group has in total 34 (2021: 40) forward foreign exchange contracts outstanding, made up of regular forward foreign exchange contracts, and more complex forward foreign exchange contracts known as Window Barrier Accruals and Counter TARNs (targeted accrual redemption note). Derivative financial instruments are carried at fair value.

 

Regular forward foreign exchange contracts:

At 31 December 2022, there were 30 (2021: 40) regular forward foreign exchange contracts, to buy US dollars and sell Euros, for an agreed amount of foreign currency on a specific future date. The purchase or sale is made at a predetermined exchange rate. The outcome is certain and will deliver a known fixed amount. The following table details the regular forward foreign exchange contracts outstanding as at the balance sheet date.

a) Contracted exchange rate

2022

2021

2022

2021

£/$

£/€

3 months or less

1.2707

1.3730

n/a

n/a

3 to 6 months

1.1447

1.3866

1.1485

1.1645

6 to 12 months

1.1407

1.3813

1.1414

1.1491

12 months or more

n/a

n/a

1.1192

n/a

 

 

b) Contract value

2022

2021

2022

2021

 

£/$

£/€

£'000

£'000

£'000

£'000

3 months or less

1,448

728

0

0

3 to 6 months

699

13,159

849

1,072

6 to 12 months

438

5,447

1,095

2,259

12 months or more

-

-

1,385

-

2,585

19,334

3,329

3,331

 

 

 

 

 

c) Foreign currency

2022

2021

2022

2021

$'000

$'000

€'000

€'000

3 months or less

1,840

1,000

0

0

3 to 6 months

800

18,250

975

1,250

6 to 12 months

500

7,535

1,250

2,600

12 months or more

0

0

1,550

0

3,140

26,785

3,775

3,850

 

Window Barrier Accrual forward foreign exchange contracts:

At 31 December 2022, there were 3 Window Barrier Accrual forward foreign exchange contracts to buy US dollars (2021: nil).

 

Window Barrier Accruals have an agreed US dollar purchase Forward Rate, a start date known as the Barrier date, an end date known as the Expiration date, a rate below which the forward foreign exchange contract becomes worthless known as the Knock Out Rate, and a Notional Amount of currency to purchase at the Forward Rate depending on the US dollar Spot Rate at the Expiration Date.

 

Each Window Barrier Accrual contract has been designed to cover the currency needs of the business throughout 2023 and includes 12 Barrier and Expiration dates, one in each calendar month, so that the forward foreign exchange contract is split evenly across the year.

 

If from month to month between the Barrier date and the following Expiration date, the Spot Rate of the US dollar falls below the Knock Out Rate, then there is no obligation, and no US dollars can be purchased. Otherwise, if on the Expiration date Spot Rate is below the Forward Rate, then the Notional Amount of US dollars will be purchased at the Forward Rate, however if on the Expiration date Spot Rate is above the Forward Rate, then double the Notional Amount of US dollars will be purchased at the Forward Rate.

 

The following table details the Window Barrier Accrual forward foreign exchange contracts outstanding as at the balance sheet date.

 

Window Barrier Accrual

Forward Rate

Barrier dates

(12 in total)

Expiration dates

 (12 in total)

Knock Out Rate

Notional Amount

Double the Notional Amount

Contract 1

$1.1950

16 Dec 2022 through to 16 Nov 2023

17 Jan 2023 through to 15 Dec 2023

$1.0590

$500,000

$1,000,000

Contract 2

$1.2020

15 Dec 2022 through to 14 Nov 2023

13 Jan 2023 through to 13 Dec 2023

$1.0590

$75,000

$150,000

Contract 3

$1.2000

15 Dec 2022 through to 14 Nov 2023

13 Jan 2023 through to 13 Dec 2023

$1.0590

$425,000

$850,000

Maximum total per month

 

 

 

 

$1,000,000

$2,000,000

 

As at 31 March 2023 the Group have purchased $6,000,000 at an average rate of $1.1976 using the Window Barrier Accrual forward foreign exchange contracts.

 

Counter TARN forward foreign exchange contracts:

At 31 December 2022, there was 1 Counter TARN forward foreign exchange contract to buy US dollars (2021: nil).

 

Counter TARNs have an agreed US dollar purchase Forward Rate, an end date known as the Expiration date, a Target which is the agreed number of times the contract allows the purchase of dollars when the Spot Rate is less than the Forward rate at the Expiration date, a Fixing Count which increments by 1 each time the contract allows the purchase of dollars when the Spot Rate is less than the Forward rate, a Notional Amount of currency to purchase at the Forward Rate depending on the US dollar Spot Rate at the Expiration Date, and a Knock Out Event which is when the Fixing Count total has reached the agreed Target and thereafter the forward foreign exchange contract becomes worthless.

 

The Counter TARN contract has been designed to cover the currency needs of the business throughout 2023 and includes 12 Expiration dates, one in each calendar month, so that the forward foreign exchange contract is split evenly across the year.

 

If from month to month on the Expiration dates Spot Rate is below the Forward Rate, then the Notional Amount of US dollars will be purchased at the Forward Rate and the Fixing Count will increment by 1, however if on the Expiration dates Spot Rate is above the Forward Rate, then double the Notional Amount of US dollars will be purchased at the Forward Rate and the Fixing Count will not change. If at any time the Fixing Count reaches the Target for the contract, then this triggers a Knock Out Event which ends the contract and no further US dollars can be purchased.

 

The following table details the Counter TARN forward foreign exchange contract outstanding as at the balance sheet date.

 

Counter TARN

Forward Rate

Expiration dates (12 in total)

Target

Notional Amount

Double the Notional Amount

Contract 1

$1.2000

12 Jan 2023 through to 13 Dec 2023

5

$500,000

$1,000,000

Maximum total per month

 

 

 

$500,000

$1,000,000

 

As at 31 March 2023 the Group have purchased $3,000,000 at a rate of $1.2000 using the Counter TARN forward foreign exchange contract.

 

Management has applied a Monte Carlo model approach when calculating the fair value of the Window Barrier Accrual and Counter TARN foreign exchange hedging instruments at the year end. This involved making assumptions and judgements around the future likely value of the US dollar compared to the Forward Rate of the exchange contracts, using statistical trials based around historic data of the US dollar exchange rate versus pound sterling. The Monte Carlo model predicted that the Window Barrier Accrual forward foreign exchange contracts would in total allow the Group to purchase $18 million, out of a possible maximum $24 million, and the Counter TARN forward foreign exchange contract would in total allow the Group to purchase $7.4 million, out of a possible maximum $12 million.

 

Foreign currency forward contract assets and liabilities are presented in the line 'Derivative financial instruments' (either as asset or as liabilities) within the Statement of Financial Position.

 

Fair value of financial assets and liabilities

 

Financial instruments are measured in accordance with the accounting policy set out in Note 1. All financial instruments carrying value approximates its fair value with the exception of foreign currency forward contracts and options which are considered Level 2. The Directors consider that there is no significant difference between the book value and fair value of the Group's financial assets and liabilities and is considered to be immaterial.

 

24. Pension costs

 

The Group operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the statement of comprehensive income in the period to which they relate. The amount charged to profit in each period was £101,003 (2021: £88,339).

 

25. Controlling party

 

In the opinion of the directors there is no ultimate controlling party.

 

26. Earnings per share

 

Basic earnings per share are calculated by dividing profit or loss attributable to ordinary equity holders by the weighted average number of ordinary shares in issue during the period.

 

The weighted average number of shares for the current year includes the shares issued as consideration for the acquisition of Retra Holdings Limited on 30 November 2017.

 

2022

2021

 

 

Basic earnings per share (pence)

8.14

3.69

Diluted earnings per share (pence)

8.11

3.68

The calculation of basic and diluted earnings per share is based on the following data:

 

2022

2021

Earnings

£'000

£'000

Earnings for the purpose of basic earnings per share, being the net profit

6,250

2,830

 

 

Number of shares

2022

2021

Weighted number of ordinary shares for the purpose of basic earnings per share

76,752,355

76,751,187

Potentially dilutive shares awarded

296,256

62,699

Weighted number of ordinary shares for the purpose of diluted earnings per share

77,048,611

76,813,886

 

4,063,881 share options (2021: 4,542,988) in issue have not been included in the computation of diluted earnings per share, as per IAS 33, the share options are not dilutive as they are not likely to be exercised given that the exercise price is higher than the average market price.

The additional 385,633 share options granted on 20 May 2020, additional 400,000 share options granted 24 May 2021, 200,000 share options granted 01 March 2022 and 20,000 share options granted 17 October 2022 have been included in the computation of diluted earnings per share as the exercise prices of the options are below the average annual market price of Ordinary shares.

27.  Notes supporting statement of cash flows

Non-cash transactions from financing activities are shown in the table below.

Non-current loans and borrowings

Current loans and borrowings

 

 

Total

£'000

£'000

£'000

 

At 1 January 2021

3,045

914

3,959

Non-cash flows

-

169

169

Cash flows

-

(981)

(981)

Reclassification from Non-current loans and borrowings to current loans and borrowings

(508)

508

-

 

At 31 December 2021

2,537

610

3,147

Non-cash flows

3,551

-

3,551

Cash flows

-

(836)

(836)

Reclassification from Non-current loans and borrowings to current loans and borrowings

(1,241)

1,241

-

At 31 December 2022

4,847

1,015

5,862

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR NKPBNOBKDOQB
Date   Source Headline
24th Apr 20247:00 amRNSResults for the year ended 31 December 2023
9th Apr 20247:00 amRNSBlock listing Interim Return
9th Apr 20247:00 amRNSTrading Update and Notice of Results
26th Mar 20242:37 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSWard & Hagon Contract Renewal
12th Jan 20247:00 amRNSTrading Update
12th Dec 20237:00 amRNSAppointment of Non-Executive Directors
1st Dec 20233:37 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSGrant of Options
21st Nov 202311:23 amRNSPDMR Dealing
20th Nov 20231:24 pmRNSHolding(s) in Company
10th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSBlock Listing Interim Return
31st Oct 20237:00 amRNSTotal Voting Rights
13th Oct 20233:38 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20233:26 pmRNSHolding(s) in Company
3rd Oct 202312:25 pmRNSBlocklisting Application
28th Sep 20235:47 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
19th Sep 20233:51 pmRNSHolding(s) in Company
12th Sep 20237:00 amRNSNotice of Results
22nd Aug 202312:31 pmRNSHolding(s) in Company
27th Jul 20234:34 pmRNSHolding(s) in Company
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20231:40 pmRNSResult of AGM
28th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSTrading Update
6th Jun 20237:00 amRNSPDMR Dealings
24th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
9th May 202311:28 amRNSHolding(s) in Company
2nd May 20234:31 pmRNSBlocklisting Application
26th Apr 20237:00 amRNSResults for the year ended 31 December 2022
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden
21st Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSChange of Adviser
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing
28th Jun 20227:00 amRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.